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Between August 1979 and September 1982, acute
variceal haemorrhage has been managed in the University
Department of Surgery, Glasgow Royal Infirmary by a
policy of oesophageal tamponade and injection
sclerotherapy. Haemorrhage was controlled in 90% of
admissions with an admission mortality of 28%.
Recurrent haemorrhage occurred in half the patients
surviving their first admission to hospital despite
entering a programme of elective sclerotherapy. The
results of this management policy are reviewed and the
means of selecting patients for more aggressive therapy
discussed. The deficiencies of a modified Child's
classification in selection of patients are highlighted
and overcome by the development of a prognostic index
obtained by regression analysis on data collected on
patients managed over this 3 year period.
The admission prognostic index clearly defines
'high' and 'low' risk groups and 'predicts' outcome
following admission in 90% of patients. The use of this
index is validated in a further group of patients
managed by a similar policy. Further regression
analysis is used to obtain a prognostic index for
alcohol cirrhotic patients alone and to determine the
factors associated with one year survival. These
indices are used to audit the management policy.
Prothrombin, creatinine and encephalopathy are shown to
have a clear association with outcome when measured at
the time of variceal haemorrhage whereas other factors
such as albumin and haemoglobin emerge as having
prognostic value when measured one month following the
acute episode.
The possible applications of these prognostic
indices are investigated in a prospective two centre
study assessing the efficacy of propranolol in
preventing recurrent variceal haemorrhage. It is shown
that they can be used to exclude patients from entry
into a study assessing the longterm benefit of
propranolol when the prospects of short-term survival
are limited. Their value in auditing management and
their possible use in withdrawing treatment are shown.
The prognostic indices are used to compare results of
treatment at the two hospitals and are shown to be of
value in analysing the results of the trial.
These prognostic indices provide an objective
means of evaluating patient management and may allow




I wish to express ray sincere gratitude to the
following:
Professor David C. Carter, St. Mungo Professor of
Surgery, Royal Infirmary, Glasgow for guiding me in my
career in surgical gastroenterology and for encouraging
me to pursue my research in the management of portal
hypertension. I thank him for his valuable advice,
criticism and encouragement.
Dr. Niall Finlayson, Consultant Physician,
Gastrointestinal and Liver Service, Royal Infirmary,
Edinburgh for acting as my supervisor for my thesis.
Dr. Peter Mills, presently Associate Professor of
Medicine, Medical College of Virginia, with whom the
protocols for the study assessing the efficacy of
propranolol in preventing recurrent variceal haemorrhage
were formulated.
Dr. Gordon Birnie, Senior
Medicine, Western Infirmary for
patients who presented to the
variceal haemorrhage and who
propranolol study.
Mr. D. Henry Osborne,
Surgeon, Jervis Street Ho
assistance with data collection
on my surgical career.
Registrar, Department of
making available data on
Western Infirmary with
were included in the
currently Consultant
spital, Dublin for his
and his early influence
- 3 -
The medical and nursing staff in the University
Department of Surgery and in particular Mr. Stephen
Blarney and Mr. John Utley who have been involved in the
management of patients presenting with variceal
haemorrhage.
Dr. Harper Gilmour and Miss Helen Motyl,
Department of Statistics, University of Glasgow for
improving my knowledge of statistical analysis.
Miss Anne McKellar for her invaluable help in the
typing and preparation of this thesis.
My wife, Amanda, for her great tolerance during
the long hours I spent in hospital managing these
patients and for her support whilst I attempted to
finish this thesis.
_ 4 -
DECLARATION OF PUBLISHED WORK
This work has been presented in part to the
Glasgow Gastroenterology Club, the Surgical Research
Society, the European Society for Surgical Research, the
International Surgical Scientific Conference (Dublin),
and the 6th Tripartite Meeting in Boston, and has been
abstracted in the following journals:
Garden, O.J., Motyl, H., Gilmour, W.H. and Carter, D.C.
Prediction of outcome following acute variceal
haemorrhage.
Br. J. Surg. 1984, 71, 378.
Garden, O.J., Motyl, H., Gilmour, W.H., Utley, R.J. and
Carter, D.C.
Prediction of outcome in alcohol cirrhotic patients
following acute variceal haemorrhage.
Europ. Soc. Surg. Res. 1984, 16, 90.
Garden, O.J., Gilmour W.H. and Carter, D.C.
Factors influencing the risk of rebleeding and one
year survival following acute variceal haemorrhage
Br. J. Surg. 1984, 71, 1006.
Mills, P.R., Garden, O.J., Birnie, G.G. and Carter, D.C.
Propranolol in the prevention of further variceal
haemorrhage in patients with cirrhosis: interim
results of a controlled trial.
Scot. Med. J. 1985, 30, 58.
This work has been published in part in the
following journals:
Garden, O.J., Osborne, D.H., Blarney, S.L. and Carter, D.C.
The management of acute variceal haemorrhage.
Aust. N.Z. J. Surg. 1983, 53, 197-202.
Garden, O.J., Motyl, H., Gilmour, W.H., Utley, R.J. and
Carter, D.C.
Prediction of outcome following admission with variceal
haemorrhage.
Br. J. Surg. 1985, 72, 91-95.
- 5 -
Garden, O.J., Utley, R.J. and Carter, D.C.
The prevention of recurrent variceal haemorrhage by
chronic injection sclerotherapy.
Scot. Med. J. 1985, 30, 148-151.
Garden, O.J., Gilmour, W.H. and Carter, D.C.
Factors influencing the risk of rebleeding and one year
survival following acute variceal haemorrhage.




1.1 Clinical and biochemical classification of 26
patients with cirrhosis described by Child
et al (1964) and used to assess risk in
patients undergoing portasystemic shunting
for variceal haemorrhage.
1.2 Survival of patients presenting with variceal 27
haemorrhage in relation to original Child's
classification and treatment.
1.3 Classification of individual variables for 28
patients presenting with variceal
haemorrhage using original Child's
classification (Graham et al, 1 98 1 ) .
1.4 Modification of Child's original 29
classification as described by Campbell et al
(1973) for use in patients presenting with
variceal haemorrhage.
1.5 Modification of Child's classification (Pugh 31
et al, 1973) to assess risk in patients
presenting with variceal haemorrhage.
2.1 Cause of portal hypertension and admission 46
mortality in 69 patients presenting on 100
occasions with acute variceal haemorrhage.
2.2 Control of haemorrhage and admission 50
mortality in relation to modified Child's
classification (after Pugh et al, 1973) for
69 patients admitted on 100 occasions with
acute variceal haemorrhage.
2.3 Admission and one year mortality in 69 58
patients presenting with acute variceal
haemorrhage assessed on admission by modified
Child's classification.
2.4 Admission and one year mortality in 59 59
patients who survived to be reassessed by
modified Child's classification (Pugh et al,
1973) at one week following admission with
acute variceal haemorrhage.
2.5 Control of variceal haemorrhage in this and 64
other reported series of patients managed
by elective injection sclerotherapy.
3.1a Characterisation of patients dying in Group 74
1 after admission with variceal haemorrhage.
3.1b Characterisation of patients in Group 2 75




'3.2 Relationship between values of normally 76
distributed individual variables and outcome
of admission in Group 1 patients presenting
with variceal haemorrhage.
3.3 Relationship between values of individual 77
variables not normally distributed and
outcome of admission in Group 1 patients
presenting with variceal haemorrhage.
3.4 Relationship of categorical variables and 78
outcome in Group 1 patients presenting with
variceal haemorrhage.
3.5 Categorical variables and outcome in alcohol 95
cirrhotic patients presenting with acute
variceal haemorrhage.
3.6 Relationship between individual variables 96
and outcome of admission in alcohol cirrhotic
patients presenting with acute variceal
haemorrhage.
4.1 Admission and one year mortality in 68 110
patients assessed by modified Child's
classification at the time of admission with
variceal haemorrhage (Pugh et al, 1973).
4.2 Admission and one year mortality in 58 111
surviving patients reassessed by modified
Child's classification seven days following
admission with variceal haemorrhage.
4.3 Relationship of categorical variables with 1 13
survival at one year in 68 patients admitted
with acute variceal haemorrhage.
4.4 Relationship between continuous variables 114
and one year survival in 68 patients admitted
with acute variceal haemorrhage.
4.5 Death occurring within one year in patients 117
presenting with acute variceal haemorrhage
where outcome was incorrectly 'predicted'.
4.6 Modified Child's classification and one 128
year survival in 53 patients assessed one
month following admission with acute variceal
haemorrhage.
4.7 Categorical variables and one year survival 130
in patients assessed one month following
acute variceal haemorrhage.
4.8 Relationship between continuous variables and 1 31
one year survival in patients assessed at one
month following acute variceal haemorrhage.
- 8 -
Table Page
5.1 Cause of portal hypertension for 67 Glasgow 148
Royal Infirmary patients admitted on 95
occasions and 27 Western Infirmary patients
presenting with variceal haemorrhage from
September 1982 to March 1985.
5.2 Control of haemorrhage and admission 149
mortality in relation to modified Child's
classification in patients presenting to
Glasgow Royal Infirmary with acute variceal
haemorrhage between September 1982 and March
1985.
5.3 Details of 68 patients presenting with acute 151
variceal haemorrhage to Glasgow Royal
Infirmary and Western Infirmary entered into
a study assessing the efficacy of propranolol
in preventing recurrent variceal haemorrhage.
5.4 Mortality and incidence of rebleeding for 68 153
patients entered into the propranolol study.
5.5 'Low' risk patients admitted between 156
September 1982 and March 1985 with acute
variceal haemorrhage and in whom outcome of
5.6 'Low' risk patients entei
propranolol study and in
'predicted'.






2/1 Life table analysis of 69 patients 61
presenting with acute variceal haemorrhage
to the University Department of Surgery
between August 1979 and September 1982.
2/2 Life table analysis of 69 patients 62
expressed in terms of modified Child's
grading (Pugh et al, 1973) assessed at the
time of initial admission with acute
variceal haemorrhage.
3/1 Probability of discharge or death for 80
patients admitted with variceal haemorrhage
in Group 1.
3/2 Relationship between log (p/1-p) and serum 82
creatinine for patients presenting with
acute variceal haemorrhage.
3/3 Relationship between log (p/1-p) and 83
prothrombin ratio for patients presenting
with acute variceal haemorrhage.
3/4 Probability of discharge or death for 84
patients admitted with variceal haemorrhage
in Group 2.
3/5 Probability of discharge or death for 98
alcohol cirrhotic patients admitted with
variceal haemorrhage in Group 1.
3/6 Probability of discharge or death for 99
alcohol cirrhotic patients admitted with
variceal haemorrhage in Group 2.
4/1 Probability of one year survival (p) for 115
patients admitted with variceal haemorrhage.
4/2 Probability of one year survival (p) for 132
patients assessed one month following acute
variceal haemorrhage.
5/1 Duration of survival (life table analysis) 154
of patients entered into study assessing
the role of propranolol in the longterm
management of variceal haemorrhage.
5/2 Risk of rebleeding (life table analysis) 155
of patients entered into study assessing
the role of propranolol in the longterm
management of variceal haemorrhage.
- 10 -
Figure Page
5/3 Prediction of outcome (p) following 158
admission for acute variceal haemorrhage
in 67 patients presenting to Glasgow Royal
Infirmary on 95 occasions with acute
variceal haemorrhage between September 1982
and March 1985.
5/4 Prediction of outcome (p) following 159
admission for alcohol cirrhotic patients
presenting to Glasgow Royal Infirmary
between September 1982 and March 1985.
5/5 Prediction of one year survival in 164
patients considered for entry to
propranolol study. Values of p
(prediction of one year survival) are given
for patients excluded and those entered
into the study from Glasgow Royal Infirmary
and Western Infirmary.
1 1 -
CHAPTER 1 HISTORICAL REVIEW
i. Introduction
ii. History of management of variceal haemorrhage
iii. Natural history of variceal haemorrhage
iv. Assessment and selection of patients in
management of portal hypertension
v. Aim of thesis
- 12 -
i. INTRODUCTION
In this review of the literature, an attempt is
made to trace the evolution of the treatment of variceal
haemorrhage and to record the natural history of this
condition. The methods used to assess the severity of
the underlying liver disease are discussed, particular
emphasis being placed on the development of
classifications and scoring systems and their use in
selecting patients for different therapeutic options.
ii. THE HISTORY OF THE MANAGEMENT OF VARICEAL
HAEMORRHAGE
Although Creuveilhier and Baumgarten described an
external collateral circulation in cirrhosis in 1829, it
was not until 10 years later that oesophageal varices
were first identified by Powers (Kleckner, 1960).
Frerichs associated the presence of oesophageal varices
and splenomegaly with cirrhosis in 1879 but it was Banti
four years later, who described the clinical syndrome
comprising cirrhosis, splenomegaly, anaemia and
haematemesis. His belief that cirrhosis was induced by
a splenic toxin subsequently misled investigators over
the next 50 years in directing surgical management of
the condition at the spleen.
By 1876 Eck had performed the first portacaval
anastomosis in dogs and had suggested that this
operation might be of value as a means of controlling
ascites in the cirrhotic patient. In 1903 Vidal, a
French surgeon, performed the first successful
- 13 -
end-to-side portacaval shunt in man for this condition
but Mclndoe (1928) was the first in the English
literature to suggest that the Eck fistula would arrest
the development of varices. By the mid 1930's opinion
had moved away from Banti's theory on the aetiology of
cirrhosis and Larrabee (1934) and Rousselot (1936)
independently identified the liver as the actual site of
obstruction causing portal hypertension.
In 1938, Rousselot and Whipple performed the first
shunt, albeit unsuccessfully, for variceal haemorrhage
in the United States of America (Grannis, 1975) and were
followed by Blakemore and Lord who performed shunts
beginning in 1942. Their work quickly established the
role of portal systemic shunting operations in the
management of bleeding oesophageal varices and with the
development of oesophageal balloon tamponade, a decade
of intense enthusiasm ensued. By 1975 it was estimated
that some 100,000 shunts had been performed worldwide
(Bengmark, 1975). However, by the 1960's several
controlled trials had cast serious doubts on the value
of shunt surgery and had shown that survival was not
enhanced for the prophylactically shunted patient
(Jackson et al, 1968 ; Resnick et al, 1 968 ; Conn et al,
1972). These studies showed that prophylactic shunts
offered no benefit over medical therapy since only
25-40% of patients with alcohol cirrhosis subsequently
bled and the poor survival and increased risk of
developing hepatic encephalopathy appeared to outweigh
the possible benefits of surgery. Although portacaval
-14-
shunt consistently reduced the risk of variceal
haemorrhage, it was not shown to significantly prolong
the duration of survival even in the therapeutically
shunted patient (Jackson et al, 1971; Resnick et al
1974; Rueff et al, 1976). In addition the control of
haemorrhage was achieved at the cost of a high incidence
of disabling encephalopathy.
Paralleling the popularity of shunt surgery in the
United States of America, several investigators in
Europe attempted a direct surgical approach to the
problem of variceal haemorrhage. In 1930, Westphal had
shown that compression of the bleeding varix with an
oesophageal sound was a simple method of arresting
haemorrhage. Several investigators in the late 1940's
(Rowantree et al, 1947) suggested that an inflatable
balloon could be used to compress the coronary veins as
they communicate with the varices. In 1950 Sengstaken
and Blakemore described the use of a three-lumen
oesophago-gastric tube which compressed the fundal and
oesophageal veins. This tube and its four-lumen
modification (Edlich et al, 1968) could be used as a
means of temporarily controlling haemorrhage but the
high risk of further haemorrhage on removal of the tube
led others to consider a more permanent direct
approach.
In 1939, Crafoord and Frenckner described the
technique of repeatedly injecting a sclerosant via an
oesophagoscope directly into the varices to control
variceal haemorrhage. Interest in this technique was
- 15 -
slow to develop because of the enthusiasm for shunt
surgery. Although it was not until 1955 that Macbeth
reported its use in the United Kingdom, Johnston and
Rogers (1973) were responsible for its general adoption
as a means of controlling variceal haemorrhage. At the
present time it appears to be the most popular method of
arresting and preventing recurrent variceal haemorrhage
in the United Kingdom (MacDougall et al, 1982; Sinnett
et al, 1982), and interest in its use is increasing in
the United States of America (Galambos, 1983). Although
sclerosis of varices via the transhepatic route has been
described, recent results would suggest that it has
limited value in the management of these patients
(Bengmark et al, 1979).
A more aggressive direct approach to the problem
of variceal haemorrhage was pursued by Boerema and Crile
who independently described trans-oesophageal ligation
of varices in 19^9 and 1950. Intermittent reports of
its successful use were described by Walker in 1964 and
by George and Pugh in 1973. Johnston in Belfast has the
largest experience of stapled oesophageal transection
but has restricted its use to the elective patient
(Johnston, 19 8 2 ). The role of this therapeutic option
in the management of bleeding varices has yet to be
defined.
Until recently, the pharmacological management of
portal hypertension was able only to produce a temporary
reduction in portal venous pressure sufficient to arrest
variceal haemorrhage. Vasopressin was first shown to
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lower portal venous pressure by Clarke in 1928, but it
was Kehne in 1956 who demonstrated that it could control
bleeding from oesophageal varices. Shaldon and
colleagues (1960) showed that it was effective in
arresting haemorrhage when given as a bolus intravenous
dose in all eight patients assessed. Although its
successful use has been recorded when infused through
the superior mesenteric artery (Conn et al, 1975), it is
more frequently given as a peripheral infusion and
control of haemorrhage is reported using this method in
9-86% of patients (Sagar et al, 1979; Freeman et al,
1982). A synthetic analogue of vasopressin, triglycl
lysine vasopressin (glypressin) , has a more prolonged
action, may have fewer side effects and may be more
effective in controlling haemorrhage (Freeman et al,
1982). Interest has recently been shown in the use of
somatostatin. Thulin and colleagues (1979) reported its
use in a series of five patients, all of whose episodes
of variceal haemorrhage was controlled. In a controlled
study, Kravetz et al (1984) showed that it was as
effective as vasopressin in controlling haemorrhage.
All these pharmacological agents offer temporary
control of haemorrhage but propranolol has been shown to
produce a sustained reduction in portal venous pressure,
liver blood flow and cardiac index (Lebrec et al,
1981). In one study of cirrhotic patients who had
gastrointestinal haemorrhage and were treated with
propranolol, the proportion who remained free of
gastrointestinal bleeding after one year was 96%
- 17 -
compared to 50% in a placebo group (Lebrec et al,
1981). However, further studies in patients with
varying degrees of liver failure and cirrhosis failed to
demonstrate any effect on rebleeding rate or survival
(Burroughs et al, 1983). Further studies are required
to determine the role of this mode of therapy in the
longterm prevention of variceal haemorrhage.
It is of interest to note that Eck recommended the
application of the portacaval fistula in man based on
experimental operations on eight dogs, seven of which
died immediately following the operative procedure, the
eighth escaping from the kennel at 10 weeks at which
time patency of the shunt was not established. The
management of portal hypertension has pursued a similar
course over the last century. Intense enthusiasm has
followed the description of each new therapeutic
modality only for enthusiasm to wane as controlled
studies have revealed their limitations.
iii. THE NATURAL HISTORY OF VARICEAL HAEMORRHAGE
Haemorrhage from oesophageal varices is relatively
uncommon accounting for between 3-5% of all cases of
upper gastrointestinal haemorrhage managed in hospital
(Hislop et al, 1966; Johnston et al, 1973; Forrest et
al, 1974). The mortality of this condition is high, the
prognosis generally being determined by the severity of
the underlying hepatocellular disease (Novis et al,
1976; Sherlock, 1982). Attempts to improve survival by
arresting haemorrhage and preventing recurrent
- 18 -
haemorrhage must take into account the natural history
of the liver disease since the management policy may
compromise liver function.
Stone and colleagues ( 1 968 ) reviewed the outcome
of 155 patients presenting over a six year period with
cirrhosis. Only 12% of this population presented with
gastrointestinal haemorrhage and in half of them, it was
a terminal event. Seventeen percent subsequently bled
from oesophageal varices and the main cause of death was
liver failure (34%) and hepatoma (18%). The five year
survival of the total population was 14%. Mortality was
worse if ascites was one of the presenting features and
in the sub-group with cryptogenic cirrhosis as the cause
of portal hypertension. Saunders and colleagues (1981)
have confirmed the poor prognosis in cryptogenic
cirrhotic patients, the five year survival of 14% being
considerably lower than 36% and 60% for alcoholic
cirrhosis and chronic active hepatitis respectively.
Death in this large series of 512 patients was most
often due to'liver failure (37%), hepatoma (20%) and
gastrointestinal haemorrhage (16%). Those patients
presenting with well compensated liver disease had a
much better prognosis than those with ascites or
encephalopathy on presentation. In alcohol cirrhotics
survival was improved in both the decompensated and
compensated patients if they abstained from alcohol.
Few studies have satisfactorily documented the
outcome for patients who have not undergone treatment
for their variceal haemorrhage. Hislop (1966) described
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the course of 63 patients presenting at two general
hospitals over a 22 year period. Thirty-four (54%) did
not survive the initial admission although three of
these underwent surgery. At five years only nine
patients had survived (14%) but 16 of the 63 patients
had undergone an operative procedure.
In a review of patients admitted with variceal
haemorrhage to the San Francisco Hospital, Cohn and
Blaisdell (1958) found that 337 (74%) of 456 patients
did not survive their first admission to hospital.
Recent studies have not shown such an unfavourable
outcome, although Novis and colleagues (1976)
demonstrated an admission mortality of 48% following
presentation with acute variceal haemorrhage in patients
not treated beyond oesophageal tamponade. A better
impression of the natural history of acute variceal
haemorrhage can be gained by looking at the outcome of
patients assigned to control groups when an active form
of therapy is being assessed. The early studies of
therapeutic portacaval shunt surgery provide such an
opportunity, albeit in a selected patient population.
In both the VA Cooperative (Jackson et al, 1971) and
Boston Inter-Hospital Liver Group studies (Resnick et
al, 1974 ) the risk of recurrent variceal haemorrhage in
non-treated patients was 65-70%. In the study of Resnick
and colleagues (1974), 67% of these episodes of variceal
haemorrhage occurred within the first year. Although
these same investigators documented episodes of variceal
haemorrhage beyond 18 months of follow-up, it should be
- 20 -
noted that 44% of these patients in the control group
underwent an emergency portacaval shunt. Jackson and
his colleagues (1971) found an identical incidence and
timing of rebleeding in their medical control group and
noted that 72% of all episodes of haemorrhage were
moderate or severe. The overall mortality of control
patients at five years was 52% and 54% for the Boston
and VA studies respectively. In the latter study the
primary cause of death was variceal haemorrhage in 41%
of the patients assigned to the medical group whereas
21% died of progression of liver disease. In the Boston
study (Resnick et al, 1974) death resulted from
recurrent variceal haemorrhage in 67% of patients.
These figures are substantiated by the experience of
Rueff and colleagues (1976) whose controlled study of
therapeutic portacaval shunt had a control group of 49
patients, 35 (71%) of whom experienced recurrent
variceal haemorrhage. Twelve of the 35 (34%) died but
seven of these patients underwent emergency shunt
surgery. One and three year survival for the control
group was 79% and 56% respectively and was not
significantly altered for those patients who underwent
emergency surgery. In interpreting these data, it has
to be borne in mind that the patients studied were a
selected population. In the VA hospital's study, the 79
patients entered were selected from a total of 832
presenting to these hospitals with acute variceal
haemorrhage. Similarly the strict entry criteria in the
study of Rueff and his colleagues (1976) resulted in the
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exclusion of 211 patients such that only 89 (30%)'
patients were deemed suitable for this study.
Given the selectivity of the patients included in
control studies of portacaval shunting, a more realistic
impression of the natural history of variceal
haemorrhage might be obtained by looking at studies
assessing less invasive therapeutic modalities. In a
more recent study assessing the efficacy of injection
sclerotherapy (MacDougall et al, 1982), only nine of 141
patients (6%) admitted with variceal haemorrhage died on
that admission. During a mean follow-up period of 9.5
months, the frequency of rebleeding was 75% in the
control group who did not receive sclerotherapy.
Moreover, the risk of rebleeding was greatest in those
patients with severe liver disease. In this same study
one year survival for the medically treated group was
58% and 77% of these deaths were thought to have been a
direct result of variceal haemorrhage. In a further
study assessing injection sclerotherapy in the longterm
prevention of recurrent variceal haemorrhage, Terblanche
and colleagues (1983) noted that 77% of patients
sustained recurrent haemorrhage and the majority of
these episodes occurred within the first six months of
presentation. The one year survival of 50% was similar
to that of the study of MacDougall and colleagues (1982)
but only 8% of deaths in the control group were as a
direct result of variceal haemorrhage. The lower
mortality due to variceal haemorrhage may be accounted
for by the fact that the control group received
- 22 -
injection sclerotherapy on each occasion that the
patient presented with acute variceal haemorrhage.
Although MacDougall and colleagues (1982) did not
undertake injection sclerotherapy for acute variceal
bleeds, 17% of their control group did undergo some form
of active treatment.
In a study assessing the efficacy of propranolol
in reducing the incidence of recurrent variceal
haemorrhage, Lebrec,and colleagues (1981 ) noted a 45%
incidence of recurrent variceal bleeding at one year in
the group of patients on placebo therapy. However,
their study was undertaken in a selected group of
cirrhotic patients who had no evidence of ascites,
encephalopathy and jaundice. In a further similar
study, Burroughs and colleagues (1983) had a similar
incidence of rebleeding (50%) in their non-treated
control group and in 18% of these patients this episode
of bleeding was fatal. Although the authors of this
latter study felt that they were dealing with a patient
population manifesting more severe liver dysfunction
than in the study of Lebrec and colleagues (1981), 60%
of the patients entered into the study were assigned to
a modified Child's grade A and 10% of their patients
were graded C. All the patients entered into this
particular study survived admission to hospital,
although seven patients died before entry into the
study, giving an admission mortality of 12%. The
follow-up period was too short to allow estimation of
one year survival.
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From a review of these controlled studies, it can
be seen that assessment of any therapeutic option must
take into account the natural history of bleeding
oesophageal varices but since the majority of deaths
associated with variceal bleeding occur soon after the
index bleed, any substantial improvement in longterm
survival must improve survival for the early period
(Graham et al, 1981 ). Most studies have purposely
excluded early mortality and this has caused
difficulties in interpreting and translating these
results to the management of all patients presenting
with acute variceal haemorrhage.
iv. ASSESSMENT AND SELECTION OF PATIENTS IN THE
MANAGEMENT OF PORTAL HYPERTENSION
In 1954, Nachlas and others readdressed the
question of survival of the variceal bleeder in an
attempt to define the role of surgery. Although 60% of
their patient population succumbed from their initial
haemorrhage, only a third of the remainder died during
the subsequent year. They noted that neither the cause
of death nor the severity of haemorrhage was related to
differences in the state of liver decompensation, though
such differences were seen in the survivors of variceal
haemorrhage. At a time when prophylactic shunts were
shown not to improve survival, the use of physiological
criteria to define the risk of surgery were becoming
accepted. The description of a classification by Child
in 1964 to record the degree of risk following
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portacaval decompression occurred when interest in the
therapeutic shunt was at its height. The classification
used five variables of liver function to grade patients
A, B or C depending upon the severity of the individual
variable (Table 1.1). Using this grading system,
survival rates decrease from grades A to C but in
comparing these studies, there is a wide disparity in
survival rates for individual grades (Table 1.2) (Foster
et al, 1971; Graham,et al, 1972; Resnick et al, 1974;
Orloff et al, 1980).
Child's original classification was rather
inflexible in grading the severity of liver disease in
that one adverse parameter, such as a low serum albumin,
was sufficient to place a patient who otherwise had good
liver function into grade C. The difficulties in using
such a subjective system were well illustrated by Graham
and Smith (1981) who found that 72% of their patient
population were assigned grade C on the basis of the
serum albumin alone but only 7% of the patients had
encephalopathy severe enough to assign them to the same
category (Table 1.3). Despite these limitations, many
investigators have persisted in using this original
classification as an indicator of operative mortality
and long-term prognosis following shunt surgery
(Shields, 1977) and as a means of selecting patients for
consideration of shunt surgery (Johnston, 1981).
Campbell and colleagues (1973) modified Child's grading
by scoring each of the individual five parameters of
liver function (Table 1.4) but it still included the
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Table 1.1 Clinical and biochemical classification of
patients with cirrhosis described by Child
et al (1964) and used to assess risk in




















nutrition excellent good poor;
'wasting'
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Table 1_.2_ Survival of patients presenting with varieeal
haemorrhage in relation to original Child's
classification and treatment.
class
author operation A B C
ADMISSION SURVIVAL
Resnick shunt 61% 21% 27%
Orloff emergency shunt 78% 60% 41%
Foster emergency shunt 100% 80% 15%
elective shunt 97% 93% 56%
ONE YEAR SURVIVAL
Graham shunt 90% 74% 51%
Orloff shunt 73% 45% 26%
Foster shunt 82% 86% -
THREE YEAR SURVIVAL
Resnick shunt 52% 26% 40%
Graham shunt 72% 54% 17%
Foster shunt 68% 72% -
FIVE YEAR SURVIVAL
Orloff shunt 55% 38% 15%
Foster shunt 33% 64% -
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Table J_. 3_ Classification of individual variables 'for
patients presenting with variceal haemorrhage
using original Child 1s classification




















overall 83 3(4%) 22(26%) 58(70%)
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Table 1.4 Modification of Child's original classification
as described by Campbell et al ( 1973) for use




bilirubin <2 mg% 2-3 mg% >3 mg%








nutrition excellent good poor




subjective assessment of nutrition. In the same year,
Pugh and his colleagues described a scoring system based
on these same variables but included prolongation of
prothrombin time and omitted the assessment of body
nutrition (Table 1.5). This modified Child's
classification has now been generally adopted as a means
of grading liver dysfunction and appears to define short
and longterm risk (Pugh et al, 1973; MacDougall et al,
1982; Sinnett et ,al, 1982; Burroughs et al, 19 8 3)
although there is a wide range of survival rates for
individual grades.
Simert and colleagues (1978) have suggested that
of the variables used in these classifications or
scoring systems, bilirubin and albumin are of value in
determining early and late survival respectively
following elective portacaval shunting. There is debate
as to whether prothrombin time can predict outcome of
elective portacaval shunting (Malt et al, 1979; Orloff
et al, 1980) but a prolonged prothrombin time has been
shown to have a significant association with admission
mortality in alcoholic hepatitis (Maddrey et al, 1978).
Novis and colleagues (1976) showed that survival
increased from 23% in those patients with jaundice,
ascites and encephalopathy on admission to 92% in those
without these manifestations.
Attempts have been made by others to use invasive
measurements as a means of predicting outcome in
patients undergoing surgical decompression of the portal
venous system. It has been suggested that appearances
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Table _1_.5_ Modification of Child ' s classification
(Pugh et al, 1973) to assess risk in




encephalopathy nil slight mod-severe
ascites nil slight mod-severe
bilirubin <34 34 - 51 >51
(pmol/I)
albumin >35 28 - 35 <28
(gm / I)
prothrombin ratio <1.3 1.3 - 1.5 >1.5




at splenoportography (Viaraonte et al, 1970), portal
venous pressure (McDermott, 1972), porto-hepatic
pressure gradient (Vinel et al, 1982) and wedged hepatic
blood flow (Warren et al, 1967) may be of value in
patient selection and outcome determination. However,
others have questioned haemodynamic selection since it
has failed to improve operative mortality or longterm
survival in shunted patients (Burchell et al, 1979;
Smith, 1979).
Kanel and colleagues (1977) found no association
between histological evidence of ongoing alcoholic
hepatitis and survival in patients with cirrhosis,
although some workers (Grendell et al, 1983) found the
presence of panlobular fat was of value in determining
outcome in patients about to undergo portasystemic
shunting, others have suggested that the presence of
acute hyaline necrosis is associated with a high
mortality (Mikkelson, 1979). In general terms, no
invasive measurement has been shown to have an advantage
over established classifications and scoring systems.
Most studies which have sought to identify good
risk patients presenting with variceal haemorrhage, have
been performed on patient populations undergoing portal
systemic shunting. Since portal systemic shunting has
been shown to have a deleterious effect upon functional
hepatic reserve, it may be inappropriate to use
selection criteria obtained from portal systemic shunt
patients to define risk in patients managed by a more
conservative policy.
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The high early mortality and the more benign later
course of variceal bleeders has been emphasised (Conn et
al, 1972; Orloff et al, 19 80; Graham et al, 1981).
Smith and Graham (1982) have shown that timing, either
of intervention or randomisation is the most important
variable in survival analysis. They have shown that one
year survival can be improved from 35% to 45% by merely
excluding those patients who failed to survive the first
two days of admission. Delaying therapy, therefore,
selects a subgroup defined as having improved short-term
and thus longterm survival. It is, of course, probable
that the value of particular predictive factors is
influenced in the same way that the results of treatment
of variceal haemorrhage are influenced by the method of
selection of patients and the timing of their entry to
the treatment programme. This may partially account for
the different survival rates observed between studies
when patient's risk is assessed by classifications and
scoring systems.
v. AIM OF THESIS
This thesis reviews the results of a specific
management policy aimed at controlling acute variceal
haemorrhage and preventing recurrent variceal bleeding.
The aims of this thesis are:
(1) to define the limitations of the
management policy which employs tamponade
and injection sclerotherapy as its main
therapeutic procedures.
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(2) to assess the value of established
classifications and scoring systems in
defining risk in patients following
admission with variceal haemorrhage.
(3) to determine whether specific risk factors
can be used to define short and long term
survival in all patients presenting with
portal hypertension and in the smaller
group of patients with alcohol associated
cirrhosis.
(4) to examine the effect of the timing of
assessment of liver function using clinical,
biochemical and haematological measurements.
The application of possible risk factors is
assessed in relation to a prospective study of beta
blocker therapy (propranolol) in the prevention of
recurrent variceal haemorrhage.
- 34 -
CHAPTER 2 MANAGEMENT OF VARICEAL HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Policy of management
(a) acute variceal haemorrhage
(b) prevention of recurrent variceal haemorrhage
iv. Admission control of haemorrhage and survival
(a) results
(b) discussion





In Glasgow Royal Infirmary, patients presenting
with variceal haemorrhage have been managed by a
standard policy in the University Department of Surgery
since August 1979. This policy aims to achieve early
localisation of the bleeding lesion with endoscopy as
part of the resuscitative process. Immediate control of
variceal haemorrhage is sought by oesophageal tamponade
where necessary and injection sclerotherapy via a rigid
Negus oesophagoscope under general anaesthesia. Stapled
oesophageal transection has been reserved for recurrent
haemorrhage not controlled by repeat injection
sclerotherapy. Those patients surviving their initial
admission to hospital were subsequently readmitted for
elective sclerotherapy using the fibreoptic endoscope up
until September 1982. From that time patients who
survived their initial admission were considered for
inclusion in a trial assessing efficacy of long acting
Propranolol in the prevention of recurrent variceal
haemorrhage.
The results of this management policy will be
analysed in this chapter to define its limitations, to
enable comparison of survival with other reported series
and to determine whether the modified Child's
classification can be used to identify patients who
might benefit from specific or alternative therapy.
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ii. PATIENTS AND METHODS
(a) Methods of Data Collection
Data were prospectively collected from patients
with variceal haemorrhage admitted to the University
Department of Surgery, Royal Infirmary, Glasgow.
Patients, referred with suspected variceal haemorrhage,
but who were subsequently found to have an alternative
source of blood loss, were excluded from this study.
Data were collected by myself from patients and
case records between August 1979 and March 1985, with
the exception of the 12 month period from August 1980 to
July 1981 when data were collected, under my direction,
by two other members of that surgical unit. The
completeness of this data collection has been verified
by cross-checking against ward admission books and Unit
discharge letter file.
A proforma was prepared by myself at the beginning
of this prospective survey (Appendix I) and completed
with the data collected on each emergency and elective
patient admission.
As a member of the Department of Surgery for four
of the six year study period, I was actively involved in
the management and investigation of patients presenting
with variceal haemorrhage and have undertaken a
considerable proportion of patient therapy. During
these four years, I was identified as the registrar who
undertook acute and longterm management of these
patients. This included passage of modified





A patient was only included in the study if
haematemesis and/or melaena or the presence of melaena
on rectal examination was observed, documented by the
patients general practitioner or a member of the
hospital medical staff. Variceal haemorrhage was
confirmed by fibreoptic endoscopy under sedation
(diazemuls up to 20 mg intravenously). Patients were
only included in the study if they had oesophageal
varices with evidence of recent bleeding (active
variceal haemorrhage, clot over a varix, red or black
spot overlying varix) or when oesophageal varices were
present in the absence of any other defined potential
cause of upper gastrointestinal haemorrhage.
liver pathology
The results of previous liver biopsies were sought
from referring hospitals. All patients admitted to the
University Department of Surgery underwent liver biopsy
or had histology obtained at post-mortem. Only those
patients with a prothrombin time prolonged by eight
seconds did not undergo biopsy but this was undertaken
on subsequent admissions if there was an improvement in
prothrombin time. Alcohol cirrhosis was assumed to be
present if portal hypertension was demonstrated by the
presence of oesophageal varices and there was a history
of alcohol abuse (provided by patient or relative).
cJ/
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history of liver disease
The onset of liver disease was recorded as the
date of first referral to a medical practitioner with
complications of liver disease (ascites, variceal
haemorrhage).
first variceal haemorrhage
If there was a history of previous admission to
hospital with upper gastrointestinal haemorrhage, this
was recorded as a previous haemorrhage from oesophageal
varices if this was confirmed at endoscopy as defined
above.
further variceal haemorrhage
Further variceal haemorrhage was assumed if on
admission there were signs of blood loss requiring blood
transfusion with or without haematemesis and melaena,
renewed evidence of hypovolaemic shock or rapidly
progressive anaemia, a drop of haemoglobin of at least 2
g/dl within 48 hours of admission. Endoscopy was used
to confirm recent haemorrhage from varices.
assessment of liver function - modified Child1s
classification
At the time of their initial admission to
hospital, patients were assessed according to Pugh ' s
modification of Child's classification (Pugh et al,
1973) by myself or the registrar involved in data
collection. When this was not undertaken at the time of
admission, patients were classified by referral to case
records. In those patients surviving the first seven
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days of admission, these five indices of liver function
(ascites, encephalopathy, albumin, bilirubin and
prothrombin ratio) were recorded and patients regraded.
Survival rates were estimated from life table analysis
(Kaplan and Meier, 1958).
iii. POLICY OF MANAGEMENT
(a_) Acute variceal haemorrhage
Patients presenting with suspected variceal
bleeding were resuscitated with plasma and blood. Fresh
frozen plasma or blood products were given as indicated
by a prolonged prothrombin or thrombin time and a low
platelet count. Vitamin K1 (10 mg intramuscular daily)
and cimetidine (400 mg qid) were administered to all
patients.
As part of the resuscitative procedure, the
bleeding site was defined by upper gastrointestinal
endoscopy. When active bleeding from oesophageal
varices was demonstrated, oesophageal tamponade was
instituted using the four lumen Minnesota tube or
modified Sengstaken-Blakemore tube (Edlich et al,
1968). The tube was always inserted by myself or a
registrar experienced in its use. The gastric balloon
was inflated with 100 mis of water and 20 mis of sodium
and meglumine codamide (Urimiro 340, Merck Ltd.). The
oesophageal balloon was inflated with air to a pressure
of 40 mmHg as indicated by an anaeroid barometer. The
tube was taped under slight tension with a spatula to
the cheek. The position of the tube was confirmed
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radiographically immediately after placement and the
patient constantly supervised by a trained nurse in the
University Department of Surgery wards. Open drainage
of the gastric and pharyngeal channels of the Minnesota
tube was supplemented by hourly aspiration. Oesophageal
tamponade was also instituted in those patients who in
the course of their admission had renewed significant
gastrointestinal blood loss as indicated by further
haematemesis or melaena, or had changes in pulse and
blood pressure suggesting further blood loss.
Lactulose (15-30 mis tid) was used to minimise or
avoid encephalopathy and where encephalopathy was
established, the rectum was irrigated through a rubber
tube with up to 8 litres of water or until a clear
return was obtained. Sedatives and analgesics were
avoided. Initially neomycin was used for prophylaxis of
encephalopathy. However, like others (Conn et al, 1977)
no additive effect to lactulose has been found and
accordingly it has not been used since August 1980.
The Minnesota tube remained in position with all
balloons inflated for up to 24 hours. The oesophageal
balloon was then deflated and the tube left in place for
up to 12 hours. If bleeding did not recur then the tube
was removed and destroyed to prevent reusage.
When the condition of the patient permitted, a
Negus oesophagoscope modified by the presence of a slot
on the trailing edge of the instrument (Bailey & Dawson,
1975) was passed under general anaesthesia and the
oesophageal varices injected with up to 20 mis of
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ethanolamine oleate through a Roberts needle. The
sclerosant was injected intravariceally in 3-5 ml
boluses through the slit cut in the trailing edge of the
oesophagoscope, and any bleeding was controlled by
rotating the oesophagoscope so that the varix was
compressed. Other varices were injected in turn after
rotating the instrument. Blood was aspirated by a large
bore suction to retain an empty oesophageal lumen during
injection sclerotherapy. Recurrent variceal haemorrhage
during the admission was treated in identical fashion.
When repeat injection sclerotherapy failed to
control haemorrhage, stapled oesophageal transection was
performed under general anesthesia through an upper
midline abdominal incision. The procedure included a
devascularisation of the greater curve with ligature of
the left coronary vein incontinuity. The oesophagus was
mobilised and peri-oesophageal veins were ligated and
divided and an attempt made to preserve both anterior
and posterior vagal trunks. Through an anterior
gastrostomy, sizers were introduced and the appropriate
EEA stapling gun passed into the lower oesophagus. A
heavy linen ligature was tied down on to the jaws of the
instrument at the oesophago-gastric junction and the
instrument tightened such that the full thickness of the
oesophageal wall was taken into the instrument.
Following firing of the gun, care was taken to withdraw
the instrument and the 'doughnut' of excised oesophagus
checked for the completeness of transection. Following
closure of the gastrostomy, the wound was closed without
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drainage of the peritoneal cavity. Splenectomy alone
was undertaken when non-variceal gastrointestinal
bleeding was difficult to control in the presence of
thrombocytopenia (platelet count <30,000 mm ) or when
inadvertently traumatised during stapled oesophageal
transection. Modified Child's grade A patients under 60
years of age with a patent portal vein, non-progressive,
non-alcohol associated disease were considered for an
elective Warren shunt (Henderson et al, 1984).
(_b) Prevention of recurrent variceal haemorrhage
Patients who had previously had admission to
hospital with acute variceal haemorrhage were readmitted
initially one month following acute variceal haemorrhage
and were entered into a programme of chronic injection
sclerotherapy. On the day of admission for elective
sclerotherapy, all patients underwent assessment which
included liver function tests, serum proteins, full
blood count, a coagulation screen (prothrombin, thrombin
and kaolin cephalin clotting times and platelet count)
and cross-matching of blood. All patients who had not
previously undergone liver biopsy on a previous
admission had this performed using a Trucut needle
inserted in the mid-axillary line using lignocaine as 1%
local anaesthetic. The severity of liver disease at the
time of elective sclerotherapy was graded using Pugh' s
modification of Child's classification.
Following an overnight fast, patients were
premedicated with atropine (0.6 mg). Using intravenous
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sedation with diazemuls, endoscopy was performed with an
Olympus GIF 1T endoscope. A maximum of 15 mis of
ethanolamine oleate was injected submucosally in amounts
of 1 ml alongside the main variceal channels using a
long flexible needle (Olympus NM-3). Injection was
commenced just proximal to the oesophago-gastric
junction and was also carried out at a more proximal
level when large varices extended high in the
oesophagus. Neither a flexible sheath nor oesophageal
tamponade was employed. Patients were discharged
following overnight observation and further elective
injections were performed initially at monthly intervals
until varices had decreased sufficiently in size to
allow injection at progressively longer intervals until
obliteration was achieved.
Recurrent acute haemorrhage necessitating
emergency readmission was treated by oesophageal
tamponade and injection sclerotherapy using the Negus
oesophagoscope under general anaesthesia. Stapled
oesophageal transection was used only where repeat
injection sclerotherapy failed to control haemorrhage.
iv. ADMISSION CONTROL OF HAEMORRHAGE AND SURVIVAL
(a) Results
Sixty-nine patients were referred for treatment of
bleeding varices between August 1979 and September
1982. The mean age of patients was 51 years (range
17-83 years). There were 47 male and 22 female
patients. The underlying cause of portal hypertension
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is shown in Table 2.1.
One patient with massive haemorrhage at the time
of endoscopy died before treatment could be instituted.
Of the remaining 68 patients, 21 were admitted on a
second occasion, eight were admitted with a third
haemorrhage and two with a fourth haemorrhage giving a
total of 100 admissions.
oesophageal tamponade
Bleeding settled without tamponade on 35 of these
admissions. Oesophageal tamponade was successful in
controlling haemorrhage on all but two of the remaining
64 admissions. The first of these two patients was
admitted with liver failure and a severe coagulopathy
and the second died of a cardio-respiratory arrest on
attempted passage of a Minnesota tube.
Variceal haemorrhage recurred during admission on
37 occasions. Reinstitution of tamponade controlled
haemorrhage in 31 of these 37 episodes. One patient
died from a respiratory arrest on attempted passage of
the tube and a further patient died from haemorrhage not
controlled by tamponade and caused by a .mucosal tear of
the oesophagus at rigid oesophagoscopy. One patient,
who pulled up the Minnesota tube with all balloons
inflated, died from massive haemorrhage and aspiration.
Post-mortem examination revealed a full thickness tear
of the oesophagus with mediastinal haematoma. Two other
patients also removed fully inflated tubes but only
complained of transient dysphagia and did not rebleed.
Thus control of haemorrhage with oesophageal
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TABLE 2_._1_ Cause of portal hypertension and admission
mortality in 69 patients presenting on
100 occasions with acute variceal haemorrhage
no. no. no.
patients admissions deaths
alcohol cirrhosis 48 72 22
primary biliary 4 6 1
cirrhosis
chronic active 4 5 1
hepatitis
cryptogenic cirrhosis 451
idiopathic 4 5 1
portal vein 3 4 0
thrombosis
post-hepatitic 1 2 1
cirrhosis
metastatic breast 1 1 1
carcinoma
Total 69 100 28
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tamponade was achieved in 92% of the 99 occasions when
tamponade was employed. The mortality directly
attributable to tamponade was 4%.
injection sclerotherapy
Injection sclerotherapy was performed on 82 of the
100 admissions with variceal haemorrhage. In the
remaining 18 admissions, the patient did not have
sclerotherapy; one patient (described above)
exsanguinated at endoscopy; four patients died from
progressive liver failure before sclerotherapy; three
patients had oesophageal transection; two patients
deemed suitable for shunting had elective surgery
without complication on the same admission; three
patients died from bleeding not controlled by tamponade;
two patients received no further treatment following
control of haemorrhage by tamponade; and in three
patients found to be bleeding from gastric varices,
haemorrhage settled without treatment in two and
following treatment with the neodymium-YAG laser in
one.
Injection sclerotherapy was undertaken on 90
occasions (seven patients underwent sclerotherapy on
more than one occasion). Complications occurred in
three instances. One patient developed pyrexia and
surgical emphysema soon after the procedure although a
gastrograffin swallow did not demonstrate an oesophageal
leak. Initial conservative treatment appeared
successful but seven days later an episode of
haematemesis was followed by signs of mediastinitis.
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Thoracotomy and oesophagectomy were performed but the
patient died from respiratory failure and septicaemia.
Histology of the resected oesophagus revealed
perforation at the site of a small squamous cell
carcinoma which had not been identified either at
fibreoptic endoscopy or rigid oesophagoscopy. One
patient developed stridor following oesophagoscopy and
required thoracotomy. One patient previously described,
had further haemorrhage which was not controlled by
tamponade after injection sclerotherapy.
oesophageal transection
Oesophageal transection was performed in ten
patients. The indication in nine was recurrent variceal
haemorrhage despite injection sclerotherapy, and in the
remaining patient transection was carried out because of
the development of laryngeal stridor following rigid
oesophagoscopy on a previous admission. Only one
patient had further haemorrhage during the admission in
which transection was performed. Five patients died
(50%) after oesophageal transection, four as a result of
multi-system failure, associated with terminal
haemorrhage in one, and one from left ventricular
failure in the immediate postoperative period.
other procedures
Splenectomy was performed in one patient who bled
from gastric erosions after treatment of bleeding
varices and whose platelet count remained consistently
3below 30,000 mm . Two patients underwent uneventful
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shunt surgery (one Warren shunt, one end-to-side
portacaval shunt), performed as an elective procedures
during the first admission with variceal haemorrhage.
Both patients who had non-cirrhotic portal hypertension
had been considered previously for elective portal
systemic shunting.
mortality and control of haemorrhage on admission
Using this policy of management, only ten of the
69 patients presenting on 100 occasions died because of
continuing blood loss; one at endoscopy before any
treatment could be instituted; two from oesophageal
tears (one as a result of oesophagoscopy and the other
from oesophageal tamponade); three patients with severe
coagulation defects continued to bleed despite
oesophageal tamponade; two patients arrested whilst
having a Minnesota tube inserted; one encephalopathic
patient with terminal liver disease had a haematemesis
which was not treated beyond tamponade; one patient with
advanced liver disease continued to bleed following
injection sclerotherapy and oesophageal tamponade.
Control of haemorrhage was, therefore, achieved on 90%
of admissions.
Fifteen patients died during their admission
primarily from liver failure but with evidence of other
system failure. Two patients died from left ventricular
failure, and one from multi-system failure and
septicaemia following oesophagectomy for a perforated
oesophagus. The admission mortality was 28% (Table
2.2).
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TABLE 2_.2_ Control of haemorrhage and admission mortality
in relation to mod ified Child's classification
(after Pugh et al, 1973) for 69 patients
admitted on 100 occasions with acute variceal
haemorrhage
Child's no. admissions control of admission




















*Grading on first presentation
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An attempt was made to assign patients according
to Child's original classification. In the absence of
an assessment of "nutritional status', patients were
graded A, B or C for each of the four criteria;
encephalopathy, ascites, serum albumin and serum
bilirubin. Of the 100 patient admissions, only seven
patients were assigned to the same grade for all four
criteria. In 30 admissions, three of four criteria were
assigned to the same grade (for example encephalopathy
A, ascites A, serum albumin A, serum bilirubin B) and in
63 admissions two of four criteria were the same. In 49
patient admissions, patients were assigned both good
risk (grade A) and bad risk (grade C) using different
criteria (for example encephalopathy A, ascites B, serum
albumin C, bilirubin B).
Table 2.2 shows the admission mortality for each
of the grades in Pugh's modified scoring system. All
patients assigned to modified Child's grade A had
haemorrhage controlled and survived admission but both
control of haemorrhage and survival was poorer for
Child's grade C patients than modified Child's grade B
patients.
(_b) Discussion
Any successful management policy should achieve
early localisation of the bleeding lesion with endoscopy
as part of the resuscitative process. Failure to use
endoscopy may result in inappropriate treatment and
Novis et al (1976) have reported that 33% of their
patients with known varices were found to be bleeding
from another site. This failure to define the source of
haemorrhage on admission may account for the poor and
variable results of vasopressin as a means of
controlling variceal haemorrhage. When used in
intravenous bolus form, control is reported in up to 50%
of cases (Conn et al, 1975; Novis et al, 1976; Sagar et
al, 1979), but vasopressin may be more effective when
administered as a continuous infusion (Sagar et al,
1979). Recent studies suggest that somatostatin may be
as effective (Kravetz et al, 1984) or better (Jenkins et
al, 1985) than continuous infusion of vasopressin in
controlling acute variceal haemorrhage.
In this series of 100 patient admissions, the
efficacy of tamponade in the primary control of variceal
haemorrhage closely matches the success rate of 85-92%
reported by others (Pitcher, 1971; Novis et al, 1976).
Oesophageal tamponade was successful in controlling
haemorrhage on 97% of occasions following admission and
only 84% of occasions when haemorrhage recurred during
admission and this supports the view that the clinician
has a limited ability to arrest haemorrhage in the
presence of severe coagulopathies seen in liver
failure. The low morbidity and mortality rates reported
in this series compared to those reported in other
studies (Edlich et al, 1968; Novis et al, 1976; Mitchell
et al, 1980) reflect the importance of management of
these patients by experienced medical and nursing
staff. Despite the concern regarding possible
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complications of oesophageal tamponade such as
aspiration, oesophageal rupture and ulceration (Reid et
al, 1960; Conn et al, 1967), the modified four lumen
Sengstaken-Blakemore tube (Minnesota tube) offers an
effective means of arresting variceal haemorrhage
(Edlich et al, 1968; Mitchell et al, 1980).
Although tamponade is effective in controlling
acute variceal haemorrhage, further bleeding will occur
on removal of the tube in over 50% of patients (Novis et
al, 1976; Mitchell et al, 1980). The poor results
obtained with emergency portacaval shunting (Orloff et
al, 1980) has led investigators to consider more
conservative therapeutic options. Although injection
sclerotherapy had first been described by Crafoord and
Frenckner in 1935, it has been Johnston and colleagues
(1973) who have been responsible for popularising this
technique as a means of controlling haemorrhage
following tamponade. Their results and those of
Terblanche et al (1979) show control of haemorrhage in
92% of admissions with an admission mortality between
18-25%. The 90% control of haemorrhage in the present
series is similar to both those studies.
Devascularisation procedures were popularised by
Boerema (1970) and Crile (1950). Transoesophageal
ligation of the varices has been shown to be effective
in arresting variceal haemorrhage (Pugh et al, 1973) and
has been facilitated in recent years by the introduction
of stapling instruments (Johnston 1981 ). In our
experience of managing acute variceal haemorrhage,
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stapled oesophageal transection has been undertaken in
patients in whom sclerotherapy has failed to control
haemorrhage, a selection factor which may account for
the high (50%) mortality rate. Nonetheless, other
investigators (Johnston et al, 1981) report an operative
mortality of 33% when the procedure is undertaken on an
emergency basis compared to 12% in patients treated
electively.
Despite control of haemorrhage in 90% of patient
admissions, the overall mortality remains high at 28%.
This mortality reflects the high proportion of alcoholic
cirrhotics with seriously impaired liver function and is
in keeping with the results of other series comprising
patients, the majority of whom have this as a cause of
portal hypertension (Pugh et al, 1973; Terblanche et al,
1979)- Although it was Child who first made a serious
attempt to match preoperative findings with subsequent
mortality and morbidity by using certain criteria which
would allow patients to be graded as good, fair or poor
risks (Child et al, 1964), other investigators have
subsequently used these criteria with much less
flexibility than was originally intended. In our
experience, attempts to assign patients to a particular
grade have been difficult in that only seven of the 100
patients had identical grading of the four criteria
measured and in 49% of admissions, patients could be
assigned to either grade A (good risk) or grade C (poor
risk) depending upon which of the four criteria were
used. The observation that many patients may not
- 54 -
readily fall into any of the three categories has led to
the description of various scoring systems (Campbell et
al, 1973; Pugh et al, 1973). Pugh and his colleagues
(1973) substituted the clinical assessment of body
nutrition with a measurement of prothrombin time. This
scoring system has been generally adopted by many
investigators and gives a useful guide to patient risk
following acute variceal haemorrhage. In the present
study, admission mortality increases from grade A to C
using this system. Although this modified scoring
system correlates reasonably well with admission
mortality, the allocation of 70% of patients to grade C
does not readily allow identification of individual
patients at risk despite the admission mortality of 35%
in this group.
v. LONGTERM CONTROL OF HAEMORRHAGE AND SURVIVAL
(a_) Results
Of the 69 patients referred for treatment of
bleeding varices between August 1979 and September 1982,
20 did not survive their first admission to hospital.
Two patients mentioned in the previous section died soon
following admission to hospital, one at endoscopy and
the other from a cardiorespiratory arrest on passage of
a Minnesota tube. One patient died of a cardiac arrest
secondary to a myocardial infarct within 48 hours of
admission and a fourth patient died in respiratory
failure and septicaemia as a result of a perforation at
the site of a squamous cell carcinoma following
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injection sclerotherapy. Seventeen patients died from
progressive liver failure. In four this was associated
with uncontrolled bleeding. Admission mortality on
first referral for these 69 patients was 29%.
Of the 48 patients who survived their initial
admission to hospital, two subsequently underwent
portacaval decompression electively, two patients have
undergone no further treatment following stapled
oesophageal transection and two patients have defaulted
from follow-up, although were known to be alive and well
12 months from their first referral. Four patients who
survived their initial admission to hospital died prior
to undergoing elective sclerotherapy. The 38 remaining
patients have undergone elective injection sclerotherapy
on 165 occasions. A mean of 2.6 injections was required
(range 1-10) to achieve variceal obliteration.
Twenty-three patients rebled on 41 occasions and all but
five of these episodes occurred before varices had been
obliterated by sclerotherapy. Four patients bled from
gastric varices but on only one occasion was surgery
required to control haemorrhage.
There have been no instances of perforation of the
oesophagus with the fibreoptic instrument and no patient
has died as a result of injection sclerotherapy.
Variceal bleeding has not occurred as a direct
complication within 48 hours of injection
sclerotherapy. Almost all patients experienced mild
retrosternal discomfort within 24 hours following
injection but only three patients subsequently presented
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with minor haematemesis which were shown endoscopically
to have been caused by oesophageal ulceration. Three
patients developed strictures which were noted at
endoscopy but in only one case was the stricture
symptomatic and requiring dilatation.
Of the 49 patients who survived their initial
admission to hospital, 21 have since died on follow-up.
In 14 death was precipitated by admission with variceal
haemorrhage: 11 of these died of severe liver failure,
in two treatment was withdrawn and one patient,
previously mentioned, died of left ventricular failure
following a myocardial infarct. The remaining seven
patients died from progressive liver failure. Table 2.3
shows the mortality following admission and at one year
following acute variceal haemorrhage for all 69 patients
and is related to the modified Child's classification
recorded at the time of the patient's initial
presentation to hospital.
Ten of the 69 patients did not survive their first
seven days of admission to hospital and in the remaining
59 patients, the individual patient's score (as measured
from Pugh's classification) improved in 27 patients,
worsened in 15 patients and remained unchanged in the
remaining 17 patients. Modified Child's grading,
however, improved in only 12 patients, worsened in three
patients and remained unchanged in the remaining 44
patients. Table 2.4 shows the outcome for those patients
regraded A, B or C at seven days from their index
variceal bleed. Overall admission mortality has
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TABLE 2.3. Admission and one year mortality in 69
patients presenting with acute variceal
haemorrhage assessed on admission by
modified Child's classification (Pugh et al,
1973)
Child's admission one year
class. n_ mortality mortality
A 5 0 0
B 16 2 (12%) 5 (31%)
C 48 18 (37%) 31 (65%)
Total 69 20 (29%) 36 (52%)
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TABLE 2_.4_ Admission and one year mortality in 59
patients who survived to be reassessed by
modified Child's classification (Pugh et al,
1973) at one week following admission with
acute variceal haemorrhage
Child's admission one year
class. n mortality mortality
A 6 0 0
B 21 2 (10%) 7 (33%)
C 32 8 (25%) 19 (59%)
Total 59 10 (17%) 26 (44%)
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improved to 83% with the exclusion of the ten patients
who did not survive to seven days. One year survival
has improved to 41% for the 32 patients graded C and has
decreased to 67% for the 21 patients regraded B. There
were no deaths at one year for the six patients graded
A.
Life table analysis of the total patient
population is shown on Figure 2/1 and is related to
modified Child's grading in Figure 2/2. Overall,
mortality was greatest at three months with a third of
patients having died at this time. At one year less
than half the total number of patients were still
alive.
(_b) Discussion
The results of treatment of variceal haemorrhage
are influenced by the method of selection of patients
and the timing of their entry to the treatment programme
(Smith & Graham, 1982). Given the variation in entry
criteria and patient populations between centres,
comparison of the results of sclerotherapy have limited
validity. Within these limitations, the results in
terms of initial control of haemorrhage and one year
survival rates are in keeping with those of patients
treated in controlled studies of elective
sclerotherapy. It now seems likely that injection
sclerotherapy not only reduces the number of episodes of
variceal haemorrhage (Terblanche et al, 1979; MacDougall


























FIGURE 2/1 Life table analysis of 69 patients presenting
with acute variceal haemorrhage to the
University Department of Surgery between
August 1979 and September 1982.
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FIGURE 2/2 Life table analysis of 69 patients expressed
in terms of modified Child's grading (Pugh
et al, 1973) assessed at the time of initial
admission with acute variceal haemorrhage.
The number of patients alive at the
beginning of each one year period is shown
for the three grades.
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(MacDougall et al, 1982). Although MacDougall and
colleagues (1982) showed a significantly improved
duration of survival with elective sclerotherapy,
Terblanche and his colleagues (1983) found no
improvement in survival over a control group which
unlike the previous study, received sclerotherapy for
recurrent episodes of variceal haemorrhage. The use of
'on demand' sclerotherapy might have been sufficient to
mask any potential effect on survival.
A 48% incidence of recurrent haemorrhage in this
series of patients is similar to that reported in other
series (Table 2.5). A reduction in the interval between
courses of injections may reduce the risk of early
recurrent bleeding but may increase the likelihood of
complications which in the present series have remained
at an acceptable rate. Although some degree of
retrosternal discomfort is invariable following
injection, the procedure is well tolerated by patients
and can be performed easily under intravenous sedation.
Ulcer formation has also become clinically apparent in
three patients but detection of such ulcers may be more
likely if endoscopy is undertaken more frequently. In
this series, haematemesis from ulceration has been minor
and has settled on conservative treatment on all three
occasions that it was diagnosed endoscopically.
Strictures may develop as a sequel to ulcer formation
(MacDougall et al, 1982; Sinnett et al 1982) but only
one patient with ulceration developed a symptomatic
stricture and this responded to dilatation.
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TABLE 2.5 Control of variceal haemorrhage in this and
other reported series of patients managed by-
elective injection sclerotherapy




no. of patients 38 51 35
studied
no. rebleeding 23 22 24
no. of bleeds 42 54 29
duration of 1078 741
follow-up
(patient months)





Recurrent haemorrhage may occur if varices are not
obliterated with repeated injections. MacDougall and
colleagues (1982) reported that in over 60% of their
patients obliteration was achieved within three months
with less than four courses of injections. Haemorrhage
was eight times more likely if varices were not
obliterated. In this series, all but six bleeds
occurred prior to variceal obliteration and in four of
these cases the site of haemorrhage was gastric
varices. It has been suggested that only gastric
varices, which are present at the time of haemorrhage
from the oesophagus, will subsequently bleed (MacDougall
et al, 1982) but others doubt whether gastric varices
are ever the source of haemorrhage (Terblanche et al,
1979). It remains to be seen whether gastric variceal
haemorrhage will present a longterm management problem
in patients undergoing elective sclerotherapy.
Although it has been the policy to use rigid
oesophagoscopy following admission with acute variceal
haemorrhage, elective submucosal injections have been
undertaken with the flexible endoscope. There is no
evidence to suggest that either technique is superior.
The rigid oesophagoscope provides good proximal
lighting, permits ready aspiration of blood by large
bore suction and allows compression of varices that have
just been injected. These benefits do not appear so
important when submucosal injections are carried out
electively. Although injection sclerotherapy with the
rigid oesophagoscope has been shown to give similar
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results to fibreoptic endoscopy, there is an increased
risk of perforation with the rigid oesophagoscope
(Terblanche et al, 1979)- It has not been found
necessary to use the flexible oesophageal sheath
(Williams et al, 1979) in elective sclerotherapy and
since its use usually requires general anaesthesia, it
has no apparent advantage over rigid oesophagoscopy in
acute variceal haemorrhage. It has been suggested,
however, that the use of the Williams sheath with
fibreoptic sclerotherapy may lead to earlier
obliteration of the varices and thereby minimise the
risk of early recurrent variceal haemorrhage (Westaby et
al, 1983 ). There is debate as to whether the sclerosant
should be injected into or around the varix. Grobe and
colleagues (1984) have shown that when intravariceal
injection is attempted using the fibreoptic instrument,
paravariceal accumulation of sclerosant occurs in 44% of
cases. Similarly, 50% of attempted intravariceal
injections using the rigid oesophagoscope resulted in
submucosal extravasation of sclerosant (Barsoum et al,
1978). The longterm results obtained with percutaneous
transhepatic portal vein catheterisation have shown that
there is an unacceptable morbidity and mortality with
selective obliteration of the coronary vein (Bengmark et
al, 1979). These workers have suggested that its use
should therefore be limited to centres familiar with the
technique and should be undertaken only in patients who
continue to have variceal haemorrhage not controlled by
per-oesophageal sclerotherapy.
- 66 -
The definitive place of sclerotherapy in the
longterm management of variceal haemorrhage is
uncertain. Few would recommend a return to an
aggressive policy of emergency portacaval shunting such
as that advocated by Orloff and colleagues (1980) and
elective shunting in unselected patients does not appear
to improve longterm survival (Jackson et al, 1971; Rueff
et al, 1976). The results of stapled oesophageal
transection are encouraging but the procedure carries a
high mortality in poor risk patients (Pugh et al,
1973). Propranolol has been shown to reduce portal
venous pressure and early clinical experience suggests
that a non-operative approach to the problem of
recurrent variceal haemorrhage may be possible (Lebrec
et al, 1981). However, these findings have yet to be
confirmed and a recent report has shown no benefit in a
group of patients with decompensated liver disease
(Burroughs et al, 1983).
The early results of this management policy, which
employs injection sclerotherapy as its main therapeutic
option, are encouraging. It remains to be seen whether
sclerotherapy or other therapeutic option can be
employed to better effect in patients selected on the
basis of their liver function. At the present time,
grading of liver dysfunction by the modified Child's
classification may not be sensitive enough to identify
individual patients who might benefit from such a
policy. The present results have shown that both
admission and one year mortality correlate reasonably
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well with individual grading of patients. Although
grading altered in a quarter of the 59 patients
surviving the first seven days of admission, regrading
of patients at this time did not readily improve the
ability of this grading system to discriminate between
those patients who would survive and those patients who
would not survive to one year. If selection of therapy
is to be based on the individual patient's liver
dysfunction, then p more sensitive method of assessing
risk must be identified.
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CHAPTER 3.
SECTION J_ - PREDICTION OF OUTCOME FOLLOWING ADMISSION
WITH ACUTE VARICEAL HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Results
(a) analysis of mortality





Child's classification (Child et al, 1964) and its
modified scoring system (Pugh et al, 1973) are widely
accepted as the mainstay of assessment of patients with
portal hypertension. Both classifications have been
used to select patients for particular treatment options
(Johnston, 1981) and to assess the comparability of
patient populations (MacDougall et al, 1982; Burroughs
et al, 1983; Terblanche et al, 1983). Most studies,
which have sought to identify good risk patients as
assessed by Child's classification, have been performed
on patient populations undergoing portal systemic
shunting. Since this form of therapy has been shown to
have a deleterious effect upon functional hepatic
reserve, it may be inappropriate to use selection
criteria obtained from portal systemic shunt patients to
define risk in patients managed by a more conservative
policy. Few investigators, however, have subjected
Child's classification or its modified scoring system to
critical evaluation in patients managed by a
conservative policy.
The previous chapter highlighted the limitations
of the modified Child's classification in defining a
high risk group when the majority of patients presenting
with variceal haemorrhage are assigned to grade C at the
time of their initial admission. This chapter will
assess the value of various risk factors in defining
risk as soon as possible after admission in patients
with acute variceal haemorrhage.
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ii. PATIENTS AND METHODS
The patient population studied comprised the same
group whose clinical management was discussed in section
iii. of Chapter 2. They included 69 patients referred
for treatment of bleeding varices between August 1979
and September 1982. During this period these patients
were admitted on a total of 100 occasions. These
patients will be referred to subsequently as Group One.
Between September 1982 and 31 January 1984, a
further 26 patients were admitted on 35 occasions with
variceal haemorrhage which was managed according to the
same protocol. There were five deaths in hospital in
this group of patients who will be referred to as Group
Two.
Patients were assessed according to Pugh' s
modification of Child's classification (Pugh et al,
1973). Age, sex, cause and duration of liver disease,
and the period of time since first variceal haemorrhage
were recorded. Patients were assessed at the time of
admission for the presence of ascites and
encephalopathy, grading them as present or absent. The
first recorded value for serum levels of bilirubin
(pmol/1), alanine aminotransferase (U/l), alkaline
phosphatase (U/l), urea (mmol/1), creatinine (pimol/1),
total protein (g/1), albumin (g/1), prothrombin ratio,
kaolin cephalin clotting ratio, thrombin ratio,
haemoglobin (g/dl), white cell (x10^/l) and platelet
Q
count (x10 /l) were recorded. Normal values for these
variables are given in Appendix 2.
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Student's t and Mann Whitney tests for independent
samples of data were used to determine the significance
of differences between the group of patients who died
and those who were discharged in terms of mean value for
each factor. Chi squared analysis was used to evaluate
whether categorical variables could predict outcome.
Stepwise logistic regression analysis (Appendix 3) was
used to minimise the number of admission factors needed
for optimal separation of patients who survived from
those who died. The analysis was performed using the
BMDP computer package programme PLR on an ICL 2988
computer (Dixon et al, 1977). The results are expressed
as mean + standard deviation for normally distributed
data and median and quartile when data were not normally
distributed.
iii. RESULTS
(_a) Analysis of Mortality
Sixty-nine consecutive patients admitted on 100
occasions had an admission mortality of 28% (Group
One). There were no deaths in the six modified Child's
grade A patients, three deaths in grade B and 25 deaths
in the 71 grade C patients. In Group-One, admission
mortality rate was 10% in the 29 patients in combined
grades A and B ("good risk") and 35% in 71 grade C
patients ("poor risk"). Using this system of good and
poor risk categories, outcome was correctly 'predicted'
in only 51% of patient admissions. In Group Two, there
were no deaths in six grade A and seven grade B
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patients, and five deaths in 22 grade C patients (23%).
Table 3.1 lists the deaths in both groups.
Twenty-two patients in Group One died in liver failure
but this was associated with a significant terminal
haemorrhage in four patients. Two patients died from
continued variceal haemorrhage after a positive decision
had been taken to withhold further treatment; the first
was a mentally retarded female with cryptogenic
cirrhosis and the second an 83 year old who had
experienced multiple admissions with haematemesis
attributable to continued alcohol abuse. Two patients
died in liver failure with uncontrolled variceal
haemorrhage in Group Two.
(_b) Potent ial Predict ive Factors and Admission Mortality
Group One
Nine individual risk factors obtained from the 100
patient admissions demonstrated a significant
association with admission mortality (Tables 3-2, 3-3,
3.4). Stepwise logistic regression analysis showed that
only prothrombin ratio (PTR), serum creatinine (CR) and
the presence of encephalopathy (ENC) (in decreasing
order of significance) were independent predictors of
mortality. The derived regression equation allows
estimation of the predicted probability of discharge.
The relationship between the probability of discharge
and the three predictors is given by
log (p/1-p) = 10.0 -4.3 PTR -0.03 CR -0.85 ENC
where the actual values of PTR and CR are entered and
- 73 -
TABLE3.1aCharacteris tionofpat entsdy ginGroupOneft radmissi nw hv c alemorrhage patientcauseofportalChild'sgrad admissionno.sexagehypertension(Pugh'smod.)p*causeofde th 7M96ACC0 .09liverfailu e,terminalble d 8M61ACC0 .09liverfailure 9M39ACB-terminalbleedduringendoscopy 10M97ACC0.66liverfailure 16M52ACC0.95**oesophagealp rforation 20F59PBCC0.17liverfailure 23M56ACC-liverfailu e,terminalble d 31M99ACC0.80**LVFafteroesophagealtransec ion 33F60ACB-liverfailure 39M79ACB0.95**myocardialinfarction 35M36ACC0.02liverfailure,terminalble d 39M39ACC0 .02liverfailure 92M95ACC0.17liverfailure 93F90ACC0.19liverfailure 50M60ACC0.10liverfailure 51M68IdiopathicC0.13liverfailure 52M92ACC0.06liverfailure 53M53ACC0.09liverfailure 55F59CAHC0.90**LVFafteroesophagealtransection 60M51ACC0.02liverfailure 69F68PHCC0.95liverfailure 72M26ACC0.17liverfailure 77F38CaC0 .05liverfailure 87F58CCC0.75**treatmentwithdrawn 93M39ACC0.00liverfailure 95M66ACC0.00liverfailure 97F51ACC0 .26liverfailure 100M63ACC0.01liverfailure (forLegends eTabl3.1b)
TABLE3•1bCharacterisationofpatientsinGroupTwdyi gfterdmissionhvar cealha morr a e patientcauseofportalChild'sgrade admissionno.sexagehypertension(Pugh'smod.)£* 102M53ACC0 .26 105M65ACC0.21 106M46ACC0.00 1M57ACC0.59 129M57ACC0.79**causeofde th treatmentwithdrawn myocardialinfarction liverfailu e,terminalble d liverfailu e,terminalbleed myocardialinfarction AC=alcoholiccirrhosis;PBC=p imaryb l arcirrho is;PHC-p the at tici CC=cryptogeniccirrhosis;CAHchronicactivehepat tis;-a ci oma;LVF=leftventricularfailure *p=robabilityfdisch rge;seetextf alculationfpro abilityvalues p=deathoccurringinl wriskgroup**
TABLE 3_.2_ Relationship between values of normally-
distributed individual variables and
outcome of admission in Group One patients









































PTR = prothrombin ratio;
KCCR = kaolin cephalin clotting ratio;
NS = not significant;
m = mean;




TABLE 3_._3 Relationship between values of individual
variables not normally distributed and
outcome of admission in Group One patients
presenting with variceal haemorrhage
variable discharge death
n median quartile n median quartile
creatinine
(pmol/I)
69 75 60,90*** 25 105 90 , 150***
bilirubin
(pmol/I)
72 55 20,110** 28 165 78,324**
urea
(mmol/I)
69 7.4 4.9,10.0* 25 9.5 6.0, 12.9*
MFB (months) 72 4.0 0,18* 28 0 0,5*




71 8.1 5.5,10.7 27 12.7 6.6,18.4
platelets
(x109/i)
72 105 70,150 28 1 18 74,190
thrombin
ratio








72 240 170,355 28 232 157,428
number of
bleeds
72 1 0,3 28 0 0,2
MFB = months since first variceal haemorrhage;





TABLE 3_-4_ Relationship of categorical variables and








































ENC is coded as -1 when absent and +1 when present.
The relationship between individual values of p
and death or discharge in these patients is shown in
Figure 3.1 (p not calculated in six patients with
unrecorded serum creatinine values). Decreasing values
of p were associated with increasing risk of death; for
example there were five deaths in 70 admissions (7%
admission mortality) when p>0.66 ('low risk'), and there
were 20 deaths in 24 admissions (83% admission
mortality) when p<0.66 ('high risk'). The five deaths
in the 'low risk' group are among those listed in Table
3.1. In all five cases, death was not obviously related
to the degree of liver failure. The outcome following
acute variceal haemorrhage was correctly 'predicted' in
90% of admissions using this p value of 0.66 as an
arbitrary discriminant between 'low' and 'high' risk
groups.
This model does not allow for any interaction
among the three variables, PTR, CR and ENC. To
determine that a useful interaction term has not been
missed, further logistic regression analysis was
performed limiting the search to the main terms and
first order interactions only. The variables chosen for
inclusion in the model were PTR, CR, ENC and CR x ENC
and the equation obtained using them was
1og(p/1 -p) =12.3 -0.04CR -4.8PTR + 1.9ENC -0.3CR x ENC
This model correctly classified 94% of patients
(two patients were incorrectly 'predicted' to die and
four patients were incorrectly 'predicted' to be
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DIED
FIGURE 3/1 Probability of discharge or death for patients
admitted with variceal haemorrhage in Group 1.
For calculation of p, see explanation in text.
An arbitrary cut-off value p = 0.66 has been
chosen to define 'high risk' (p<0.66) and
'low risk' groups (p>0.66).
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discharged). This more complex model, by employing the
interaction term (CR x ENC), is, in practice, only a
slight improvement on the previous equation.
An important assumption when using logistic
regression analysis (Appendix 3) on any set of data is
that each continuous variable is linearly related with
the log (p/1 -p). This assumption was tested for the
two variables PTR and CR. Figure 3/2 demonstrates that
this assumption appears to hold for CR but not for PTR
which, as shown in Figure 3/3, has a quadratic shape
suggesting that a squared PTR term is required. A
squared PTR variable was created and added to the list
of existing variables and a logistic regression analysis
performed. The programme chose the variables (PTR)2,
PTR, ENC and CR for inclusion in the model such that
1og(p/1 -p) = -9-85 -8.97(PTR)2 -0.3CR + 23-3PTR -0.73ENC
This does not improve prediction over the simple model
in that it correctly classified 90% of patient
admissions. Furthermore, there is no clinical reason
for the poor prognosis associated with a low prothrombin
ratio as opposed to middle range prothrombin ratio
values.
Group Two
Using the regression equation derived from Group
One patients (simple model), the individual value for
each of the 35 patient admissions was determined (Fig.
3/4). There were four deaths in eight admissions when
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FIGURE 3/2 Relationship between log (p/1-p) and serum
creatinine (expressed as a range of values)
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FIGURE 3/3 Relationship between log (p/1-p) and
prothrombin ratio (expressed as a range















FIGURE 3/4 Probability of discharge or death for
patients admitted with variceal haemorrhage
in Group 2. For calculation of p, see
explanation in text. An arbitrary cut-off
value of p = 0.66 has been chosen to define
'high risk' (p<0.66) and 'low risk' groups
(p>0.66).
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failure within a week of discharge from hospital. All
but one of the 24 patients with a p>0.66 survived and
the one death occurred in a patient who developed a
cardiac arrest 24 hours following injection
sclerotherapy.
Whereas the simple model wrongly classifies five
patient admissions, the interaction model (CR x ENC)
makes eight errors and the squared PTR (PTR)2 model
results in seven wrong classifications. The results of
this small prospective group of patients seems to


















following acute variceal haemorrhage in
admissions of Group One was 28% and it
that nine of the 21 potential predictive
group had a significant association with
ality. Stepwise logistic regression
ified prothrombin ratio, serum creatinine
e of encephalopathy (in decreasing order
e) as having independent significance in
mission mortality. The lower admission
14% in the Group Two patients cannot be
y alteration in management but may relate
relatively smaller proportion of grade C
lysis of outcome in this second series of
the derived regression equation suggests
nostic index is soundly based, although
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experience with more high risk patients will be required
to sustain this conclusion. The total number of
admissions rather than the actual number of patients has
been analysed because outcome was not always the same on
each admission. Although patients readmitted with
variceal haemorrhage might be expected to have an
improved outcome over initial admissions, univariate
analysis showed that the number of previous bleeds did
not have a significant effect on outcome.
Cello and colleagues (1981 ) have claimed that
Child's original classification which included a
clinical assessment of nutrition, ascites and
encephalopathy, was the most important factor in
determining early mortality after portacaval shunt. In
their study, however, only 3^% of patients were assigned
to grade C, although the admission mortality in this
group was 53%. Outcome was correctly predicted in 77%
of their patient admissions. In the present study, 71%
of the patient population with variceal haemorrhage were
consigned to Child's C grade when first seen and using
the Child's predictive system, outcome is correctly
predicted in only 51% of admissions. Foster and
colleagues (1971) demonstrated an admission mortality of
85% in Child grade C patients following shunt surgery
compared to 0% and 20% in the grade A and B patients
respectively. They found this grading sysem useful in
assessing risk following elective shunt surgery but the
subjectivity of their grading was called into question
by the finding that longterm survival was significantly
- 86 -
better in grade B than grade A patients. The usefulness
of Child's grading in predicting admission mortality has
been questioned by Simert and colleagues (1978) who
found that bilirubin was the best predictor of early
survival. Campbell and colleagues (1973) have described
a scoring system to grade the severity of the five
individual factors described by Child but allocation to
high and low risk groups proved correct in terms of
admission mortality in only 62% of their total patient
population. The addition of other preoperative
parameters did not improve the predictive value of this
scoring system.
The present analysis highlights the predictive
value of admission prothrombin ratio and is in keeping
with its arbitrary inclusion in Pugh' s modification of
Child's original classification (Pugh et al, 1973).
There is debate as to whether prothrombin time can
predict outcome after elective portacaval shunting (Malt
et al, 1979; Orloff et al, 1980) but a prolonged
prothrombin time has been shown to have an independently
significant association with admission mortality in
alcoholic hepatitis (Maddrey et al, 1978). In a
controlled study of portacaval shunting, Jackson and
colleagues (1971) noted that an abnormal prothrombin
time was associated with poorer survival in control
patients although the same observation did not hold for
the shunted group. It is, of course, probable that the
value of particular predictive factors is influenced in
the same way that the results of treatment of variceal
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haemorrhage are influenced by the method of selection of
patients and the timing of their entry to the treatment
programme (Smith et al, 1982).
The inclusion of serum albumin and bilirubin (or
jaundice) as in Child's and Pugh's classifications does
not enhance prediction in the present patient population
when the severity of liver disease is assessed in the
period immediately following acute variceal
haemorrhage. Although Simert and colleagues (1978) have
suggested that bilirubin and albumin are of value in
determining early and late survival respectively
following elective portacaval shunting, the present
analysis has shown no association between serum albumin
and admission mortality and that serum bilirubin had no
independent significance. Maddrey and others (1978)
have shown that serum bilirubin is independently
associated with admission mortality in alcoholic
hepatitis. Since changes in kaolin cephalin clotting
ratio closely match those of prothrombin ratio, serum
creatinine has been identified as the second most
important predictive factor by regression analysis.
Although creatinine is of value in predicting outcome
following surgery for obstructive jaundice (Blarney et
al, 1983), its predictive value in portal hypertension
has not previously been noted.
Attempts have been made by others to use invasive
measurements as a means of predicting outcome in
patients undergoing surgical decompression of the portal
venous system. It has been suggested that appearances
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at splenoportography (Warren et al, 1967; Viamonte et
al, 1970), portal venous pressure (McDermot et al,
1972), porto-hepatic pressure gradient (Warren et al,
1967; Vinel et al, 1982), and wedged hepatic blood flow
(Warren et al, 1967) may be of value in patient
selection and outcome determination. Many of these
studies have only assessed such measurements in patients
undergoing elective surgery and others (Burchell et al,
1974 ; Smith, 1974) have questioned haemodynamic
selection since it has failed to improve operative
mortality or longterm survival in shunted patients. The
value of such invasive measurements in assessing
patients managed primarily by sclerotherapy has yet to
be determined.
With regard to the predictive value of liver
histology, Kanel and colleagues (1977) found no
association between histological evidence of ongoing
alcoholic hepatitis and survival in patients with
cirrhosis. On the other hand, Grendell and co-workers
(1983) using linear logistic regression analysis found
the presence of panlobular fat taken in association with
haematocrit could be used to predict outcome in 79% of
patients about to undergo portaystemic shunting. This
two variable combination was not improved by addition of
prothrombin time. The use of histological features to
predict outcome have not been used in the present
patient analysis since liver biopsy may be
contraindicated in the presence of - a prolonged
prothrombin time.
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The logistic regression equation obtained from the
100 Group One admissions has clearly identified a high
and low risk group of patients based on three variables
which can be readily obtained within a few hours of
admission to hospital. The value of these variables has
been verified in a second independent group of patients
and their use in assessing outcome following variceal
haemorrhage appears to have considerable advantage over
Child's and Pugh ' s classifications. Further analysis is
required, however, to determine whether this prognostic
index is still of value once the patient's clinical
condition has stabilised and within specific patient
populations since certain predictive factors may assume
greater importance in patients such as those with
alcoholic cirrhosis.
Nonetheless this analysis may be of value in a
continuing audit of patients admitted with variceal
haemorrhage and it is conceivable that it may offer a
useful means of selection for entry to clinical trials.
Graham and Smith (1981) have highlighted the dangers of
delaying the entry of patients into clinical studies of
portal hypertension. The prognostic index may provide a
method which will enable identification of patients
whose short-term survival is so poor that entry into
long term studies is not justified. This means of
selection based on liver function would not be possible
in the present patient population by means of a scoring
system such as the modified Child's classification. It
is also arguable whether the prognostic index can be
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used to identify that group of patients whose




SECTION 2 - PREDICTION OF OUTCOME IN ALCOHOL CIRRHOTIC
PATIENTS FOLLOWING ACUTE VARICEAL HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Results
(a) analysis of mortality and modified Child's
classification





In the previous section, the cause of portal
hypertension did not appear to have a significant
association with outcome but this may have resulted from
the small numbers of patients with non-alcohol
associated cirrhosis. In order to determine whether the
same variables which 'predicted' admission mortality in
all patients are also applicable to the subgroup of
patients with alcohol associated cirrhosis, a similar
statistical analysis has been performed.
ii. PATIENTS AND METHODS
Patients admitted between 1st August 1979 and 31st
September 1982 were analysed. Of the 69 patients
previously described in Section 1 of this chapter, only
49 patients satisfied the criteria for diagnosis of
alcohol associated cirrhosis. These patients were
admitted on 72 occasions (Group One) and were managed by
the same policy of tamponade, sclerotherapy and stapled
oesophageal transection as described in Chapter 2. From
1st October 1982 to 31st January 1984, 20 alcohol
cirrhotic patients were admitted on 22 occasions with
variceal haemorrhage and were managed by a similar
protocol (Group Two).
Patients were assessed using the modified Child's
classification immediately following admission. The 20
potential predictive factors described in the previous
section were analysed by Student's t, Mann-Whitney and
Chi squared tests. Stepwise logistic regression
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analysis was employed to identify those variables which
had independent significance and minimise the number of
admission factors needed for optimal separation of
patients who survived from those who died.
iii. RESULTS
(ci) Analysis of Mortality and Modified Child' s Grading
Overall admission mortality was 31% in the 72
Group One patient admissions. None of the three grade A
patients, three of 13 grade B and 19 of 56 grade C
patients died. Admission mortality was 19% in the
combined grade A and B (good risk) patients and 34% in
the remaining 56 grade C (poor risk) patients. Outcome
was, therefore, correctly 'predicted' in 55% of
admissions. In Group Two, there were no deaths in three
grade A and B patients and four deaths in 19 group C
patients (21%).
(Jb) Potential Predictive Factors and Admission Mortality
Group One
Chi squared analysis (Table 3.5) demonstrated that
of the categorical variables, only encephalopathy had a
significant association with outcome. Of the continuous
variables, prothrombin ratio, kaolin cephalin clotting
ratio, serum creatinine, serum bilirubin, serum urea and
white blood cell count were significantly greater in
those patients who died than in those patients who did
not survive admission to hospital (Table 3.6).
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TABLE 3_.5_ Categorical variables and outcome in alcohol
cirrhotic patients presenting with acute
variceal haemorrhage
variable no. of admissions died £ value
encephalopathy
absent 43 8 <0.01
present 29 14
ascites
absent 10 1 NS
present 62 21
sex
male 60 19 NS
female 12 3
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TABLE 3.6 Relationship between individual variables and
outcome of admission in alcohol cirrhotic
patients presenting with acute variceal
haemorrhage
variable discharge death £ value
value* value*
PTR 1.4 + 0.2 1.9 + 0.4 <0.001
KCCR 1.3 + 0.2 1.7 + 0.4 <0.001
creatinine 80 60,92 1 10 90, 170 <0 .001
bilirubin 56 30, 100 175 37,287 <0.01
urea 7.0 5.0,10.5 10.5 5.9,14.5 <0.01
WBC 8.3 5.9,12.0 12.2 5.6,18.4 <0.01
albumin 32.2 + 5.6 29.6 + 6.7 NS
haemoglobin 10.5 + 2.2 11.4 + 2.5 NS
MFB 2.0 0,9 0 0,4 NS
TR 1 .0 1.0,1.1 1 . 1 1.0,1.1 NS
ALT 32 21 ,45 46 29,63 NS
age 53 + 13 50 + 12 NS
platelets 110 80,150 113 62,188 NS
MLD 7.5 1 ,23 6.0 0 ,24 NS
protein 64. 1 + 9.0 62.6 + 7.9 NS
alkaline
phosphatase
244 190,340 209 141,335 NS
*mean £ SD or median and quartile
NS = not significant
PTR = prothrombin ratio
KCCR = kaolin cephalin clotting ratio
WBC = white blood count
MFB = months since first variceal haemorrhage
TR = thrombin ratio
ALT = alanine aminotransferase
MLD = duration of liver disease in months
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Stepwise logistic regression analysis showed that
only prothrombin ratio (PTR) and serum creatinine (CR)
were independent predictors of admission mortality. The
derived regression equation allows estimation of the
predicted probability of discharge (p). The
relationship between the probability of discharge and
the two predictors is given by
Log p/1 -p = 11.7 -5.7 PTR -0.02 CR
In Figure 3/5, individual values of p have been plotted
for those patients who died and those patients who
survived admission to hospital. Decreasing values of p
were associated with increasing risk of death. When
p>0.4 there were six deaths in 53 patients ('low risk'
group) and all 13 patients died when p<0.4 ('high risk'
group). Outcome was correctly 'predicted' in 92% of
admissions.
Of the six deaths in the 'low risk' group, four
were not obviously related to their liver disease.
These included the patients described in the previous
section who died as a result of oesophageal perforation,
myocardial infarct, left ventricular failure and
following withdrawal of treatment.
Group Two
Using the regression equation derived from Group
One patients, the individual value for each of the 22
patient admissions was determined (Fig. 3/6). Both
patients with a p value less than 0.4 died and all but


















FIGURE 3/5 Probability of discharge or death for
alcohol cirrhotic patients admitted with
variceal haemorrhage in Group 1. For calculati
of p, see explanation in text. An arbitrary
cut-off value p = 0.4 has been chosen to
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FIGURE 3/6 Probability of discharge or death for
for alcohol cirrhotic patients admitted
with variceal haemorrhage in Group 2.
For calculation of p, see explanation
in text. An arbitrary cut-off value
p = 0.4 has been chosen to define 'high
risk' (p<0.4) and 'low risk' groups
(p>0.4).
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was in a patient who developed a cardiac arrest 24 hours
following injection sclerotherapy and the other was in a
patient whose liver failure progressed during his
admission and died with terminal variceal haemorrhage.
iv. DISCUSSION
In the smaller subgroup of patients with alcoholic
cirrhosis, admission mortality of 31% was only slightly
greater than the , 28% admission mortality for the 100
patients presenting with acute variceal haemorrhage
(Section iii). Despite a relative increase of the
proportion of modified Child's grade C patients (78%
versus 71%), the present analysis has, however, again
clearly identified 'high' and 'low risk' groups of
patients. Indeed there was a 100% mortality in the 13
patients assigned to the 'high risk' group compared to
an 11% mortality in the 'low risk' group. Outcome has
been correctly 'predicted' in 92% of patient admissions
whereas the modified Child's classification could only
do so in 55% of the patient population.
Although the same variables which had a
significant association with outcome in all patients
retain their significance in patients with alcohol
cirrhosis, only prothrombin ratio and creatinine have
independent significance. The loss of encephalopathy as
a predictor of outcome in this subgroup of patients may
reflect the difficulties in clinically establishing the
presence of encephalopathy in patients whose confusional
state may be related to alcohol excess or an acute
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alcohol withdrawal state at the time of admission.
Furthermore, the proportion of alcohol cirrhotic
patients with encephalopathy on admission is greater
than in those patients whose portal hypertension is
secondary to other causes thereby reducing its
discriminatory ability. Novis and colleagues (1976)
recognised the presence of encephalopathy on admission
was an unfavourable prognostic sign and noted an
admission mortality of 77% when patients with acute
variceal haemorrhage showed evidence of encephalopathy,
ascites and jaundice on admission. The continued
presence of encephalopathy following admission may be
useful in determining outcome but its prognostic value
is limited given that both prothrombin ratio and
creatinine can be estimated within hours of admission to
hospital and, when these factors are taken together,
they can 'predict' outcome in all but 8% of the present
patient population. It is, of course, possible that the
subjective clinical assessment of encephalopathy is
limited but the use of objective tests such as
electroencephalograms and trail testing might be useful
in revealing evidence of subclinical encephalopathy
(Zeegen et al, 1970) or differentiating between
encephalopathy and alcohol induced toxic state.
Regression analysis has determined that the
presence of other acknowledged 'markers' of liver
function do not have independent significance. Simert
and colleagues (1978) noted that the presence of ascites
and hyperbilirubinaemia before elective surgery were
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useful indicators of survival at one month. In the
present study, 62 of the 72 patients were judged
clinically to have ascites on admission and all but one
death occurred in this group. Similarly, those patients
who survived admission to hospital had a lower admission
serum bilirubin than those who died but the differences
were not large enough to improve upon the predictive
equation containing prothrombin ratio and creatinine.
It is conceivable that changes in bilirubin and in the
presence of ascites during the patients admission may
help in determining outcome and this may account for the
observations by Simert and colleagues (1978) that the
continued presence of ascites and jaundice before
elective surgery were unfavourable signs.
Kanel and colleagues (1977) stated that once a
patient with cirrhosis has bled from oesophageal
varices, the aetiology of the cirrhosis was not a major
factor in determining survival after therapeutic
portacaval shunt. Their study, however, comprised only
82 patients, 45 of whom had histological and clinical
criteria acceptable for a diagnosis of alcohol
cirrhosis. They determined that hepatic reserve as
defined by Child's classification provided the best
criteria for predicting survival. On the other hand,
Campbell and others (1973) undertook a study of Child's
criteria and survival following shunt surgery and
correctly identified 59% of all short-term survivors
following shunt surgery. They found that prediction of
short-term survival in post-necrotic cirrhosis was 75%
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but was only 50% in the alcohol cirrhotic group. In a
further study assessing factors which influenced
survival following therapeutic shunts, Cello and
colleagues (1981) made no attempt to separate those
patients with alcohol cirrhosis from those with other
causes of portal hypertension. The present analysis on
all patients with portal hypertension and in the
subgroup of patients with alcohol cirrhosis has
suggested that the factors predicting outcome may be
related to the aetiology of the portal hypertension.
Grendell and colleagues (1983) have shown that
certain pre-shunt hepatic histological features such as
the presence of panlobular fat, either taken alone or in
combination with other factors, may be useful predictors
of short-term survival. Mikkelson (1974) reported an
adverse effect on survival after portacaval shunt when
acute hilar necrosis was present on liver biopsy but
neither Cello and colleagues (1981) nor Kanel and
colleagues (1977) could demonstrate such an
association. Kanel and colleagues (1977) did show that
active inflammation and peacemeal necrosis in patients
with chronic active liver disease was associated with a
higher operative mortality following shunt surgery. The
histological activity of liver disease in alcoholic
cirrhosis showed no such trend. None of these studies
took account of the timing of liver biopsy relative to
the patients admission and further investigation is
required to determine whether histological features may
be useful in determining prognosis. It would be
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difficult for the presence of certain histological
features to improve on the prediction obtained with
prothrombin ratio and creatinine, both of which can be
measured immediately following admission. Orloff ( 1 980 )
did not assess the effect on survival of liver histology
following emergency portacaval shunt but using SGOT as
an indicator of hepatocellular damage, he noted that
there was a 70% survival rate if levels were lower than
100 u/1 on admission whereas only 43% survived above
this level. In the present study, alanine
aminotransferase has not been of value in predicting
outcome but in both the subgroup of alcohol cirrhotic
patients and in all portal hypertensive patients,
alanine aminotransferase levels have been higher in
patients who did not survive admission to hospital. It
is debatable whether this potential prognostic factor or
indeed other factors would have predicted outcome if the
present management policy had included emergency
portacaval shunting as its main therapeutic option.
Although Adamsons and colleagues (1977) have suggested
that portal pressure measurements may help to predict
when variceal haemorrhage will be controlled, the use of
such measurements have not found much favour in recent
years (Burchell et al 1974; Smith, 1974).
A combination of clinical, biochemical and
haematological indices can be used to 'predict' outcome
in patients presenting with acute variceal haemorrhage.
Although only prothrombin ratio and serum creatinine on
admission identify a 'high risk' group amongst the
- 104 -
alcoholic cirrhotic patients, the presence of
encephalopathy taken with these two other factors aid
prediction in all patients irrespective of the
underlying aetiology of portal hypertension. Further
analysis is required to establish whether these same
indices of .liver function are of value in determining
long term survival and to establish whether the timing
of such measurements alters their significance.
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CHAPTER 4
SECTION _1_ - PREDICTION OF ONE YEAR SURVIVAL FOLLOWING
ACUTE VARICEAL HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Results
(a) Modified Child's grading and one year
survival





Although reduction in portal venous pressure by
portacaval decompression effectively prevents recurrent
variceal haemorrhage, the operation is attended by a
significant postoperative mortality (Conn, 1974; Orloff
et al, 1980), increased risk of encephalopathy (Malt et
al, 1976; Rueff et al, 1976) and no apparent improvement
in longterm survival when compared with conservative
therapy (Jackson et al, 1971; Resnick et al, 1974). It
has been shown that beta blockade therapy can reduce
portal venous pressure in cirrhotic patients with portal
hypertension (Lebrec et al, 1 980 ) . Although Lebrec and
colleagues ( 19 81 ) subsequently demonstrated a
significant reduction in recurrent haemorrhage in
treated patients, the use of adjuvant beta blockade with
agents such as propranolol has not been sustained
universally, with further haemorrhage being reported in
up to 46% of patients receiving this drug (Burroughs et
al, 1983). The move to a more conservative management
policy in many centres has resulted from the encouraging
results of injection sclerotherapy (Johnston et al,
1973; MacDougall et al, 1982; Terblanche et al, 1983)
but the high incidence of recurrent variceal haemorrhage
experienced in such treatment programmes suggests that a
more aggressive policy such as stapled oesophageal
transection might be more appropriate for a selected
group of patients.
Selection of patients for tailored treatment
options might be facilitated if high risk patients could
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be identified at an early stage in management. In the
previous chapter, certain indices of liver function have
been demonstrated to have considerable 'advantage over
classifications and scoring systems in predicting short
term survival following admission with acute variceal
haemorrhage. This chapter will concern itself with
whether these same indices of liver function can be used
to 'predict' long term survival for individual patients
and will investigate the effect on survival prediction
of delaying by one month the assessment of these
patients. The therapeutic implications of assessing the
severity of liver disease by such methods is discussed.
ii. PATIENTS AND METHODS
The patient population to be studied comprises the
same group whose clinical management was discussed in
Chapters 2 and 3. They include 69 patients referred for
treatment of bleeding varices between August 1979 and
September 1982. The one patient with idiopathic portal
hypertension who subsequently underwent elective
portacaval decompression has been excluded from further
analysis since his management differed considerably from
the remaining 68 patients.
Patient assessment was undertaken (as in Section
1, Chapter 3) immediately following initial admission to
hospital with variceal haemorrhage. The 20 potential
predictive factors were analysed by Student's t,
Mann-Whitney and Chi squared tests. Stepwise logistic
regression analysis was used to identify those variables
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which had independent significance and minimise the
number of admission factors needed for optimal
separation of patients who survived from those who
died.
Patients were assessed by modified Child's grading
at the time of admission to hospital with variceal
haemorrhage and 7 days following admission.
iii. RESULTS
(a) Modified Child's grading and one year survival
Sixty-eight patients had a one year survival of
47% and a rebleeding rate of 32%. The results of
management policy in relation to survival have
previously been discussed in Section 4b of Chapter 2.
All five grade A, 13 of the 15 (81%) grade B and 30 of
48 (62%) grade C patients survived admission to hospital
(Table 4.1). Ten patients did not survive seven days in
hospital and of the remaining 58 patients, modified
Child's grading improved in twelve and deteriorated in
three patients. All six patients regraded A, 18 of 20
(90%) grade B and 24 of 32 (75%) grade C patients
survived admission to hospital (Table 4.2).
In the 68 patients graded at the time of
admission, one year survival was 100% in grade A, 65% in
grade B and 35% in grade C patients. In the 58
surviving patients regraded at one week following
admission, one year survival was 100% in grade A, 65% in
grade B and 31% in grade C (Table 4.2).
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TABLE 4_.Admission and one year mortality in 68
patients assessed by a. modified Child' s
classification at the time of admission



















TABLE 4_.2_ Admission and one year mortality in 58
surviving patients reassessed by a modified
Child's classification seven days following
admission with variceal haemorrhage



















(b) Potential predictive factors and one year survival
Nine individual risk factors demonstrated a
significant association with one year survival (Table
4.3 and 4.4). Stepwise logistic regression analysis
showed that only the presence of encephalopathy (ENC),
prothrombin ratio (PTR) and serum creatinine (CR) (in
decreasing order of significance) were independent
predictors of mortality. The derived regression
equation allows estimation of the predictive probability
of survival. The relationship between the probability
of one year survival (p) and the three predictors is
given by
log p/1 -p = 7.8 -0.76 ENC -2.7 PTR -0.05 CR
where the actual values of PTR and CR are entered and
ENC is coded as -1 when absent and +1 when present.
The relationship between individual values of p
and death or survival at one year is shown in Figure 4/1
(p not calculated in five patients with unrecorded serum
creatinine). Decreasing values of p were associated
with increasing risk of death; for example, there were
seven deaths in 32 patients (22% mortality) when p>0.05
('low risk') and there were 26 deaths in 31 admissions
(84% mortality) when p<0.05 ('high risk'). The outcome
following acute variceal haemorrhage was correctly
'predicted' in 81% of admissions using this p value of
0.5 as an arbitrary discriminant between 'high' and
'low' risk groups.
Of the seven deaths which were 'incorrectly
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TABLE 3_ Relationship of categorical variables with
survival at one year in 68 patients admitted



































NS = not significant
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TABLE 4_.4_ Relationship between continuous variables
and one year survival in 68 patients admitted
with acute variceal haemorrhage
factor alive dead
n value n value
PTR 32 1.3 + 0.2*** 36 1.6 + 0.4***
KCCR 32 1.2 + 0.2*** 34 1.5 + 0.4***
creatinine 31 70 60,85*** 33 100 90,121***
urea 31
'
5.9 4.2,90** 33 9.5 7.5,12.5**
bilirubin 32 72 32,140* 36 108 42, 199*
white cell
count
32 9.1 + 5.0* 35 12.4 + 7.9*
thrombin
ratio
32 1 .0 1.0,1.1 34 1 .1 1.0,1.1
haemoglobin 32 10.9 ± 2 • 3 36 1 1.4 + 2.5
age 32 51 + 15 36 52 + 14
albumin 32 32.3 + 4.9 36 30.4 + 6.7
protein 32 63.4 + 9.2 36 61 .7 + 9.5
MFB 32 0 0, 12 36 0 0,0
MLD 32 15 1 ,72 36 1 0,25
platelets 32 100 71,156 36 109 75,171
ALT 32 34 21,44 36 35 24 , 64
APH 32 248 173,352 36 233 152,407




PTR = prothrombin ratio;
KCCR = kaolin cephalin clotting ratio;
MFB = months since first bleed;
MLD = duration of liver disease in months;
ALT = alanine aminotransferase;



















FIGURE 4/1 Probability of one year survival (p) for
patients admitted with variceal haemorrhage.
For calculation of p values, see explanation
in text. An arbitrary cut-off value of
p = 0.5 has been chosen to define 'high
risk' (p<0.5) and 'low risk' groups (p>0.5).
-115-
predicted' (Table 4.5), four patients died following
rebleeding and two of these deaths were associated with
progressive liver failure (patients 18 and 44), two
deaths were treatment related (patient numbers 11 and
40), whilst one patient (patient number 21) died of a
myocardial infarct.
iv. DISCUSSION
This analysis demonstrates that the admission
prothrombin ratio, a factor in both Child's
classification and Pugh's modification, is one of the
most powerful predictors of one year survival and in
association with serum creatinine and the presence of
encephalopathy, can 'predict' survival at one year in
81% of patients. Since the majority of deaths in this
and other series (Pugh et al, 1973; Novis et al, 1976;
Graham et al, 1981; Cello et al, 1981) following
variceal haemorrhage occurs soon after the index
bleeding episode, it might be anticipated that factors
which predict admission mortality also predict death by
one year. However, Malt and Malt (1979) have shown that
prothrombin time, although a predictor of survival at
two and five years, did not correlate with immediate
survival after portacaval shunt surgery. Their finding
that preoperative bilirubin and albumin were the best
predictors of operative mortality and longterm survival
are at variance with the present results. This
difference may be related in part to a different
management policy or to the heterogeneous population of
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TABLE 4_._5 Deaths occurring within one year in patients
presenting with acute variceal haemorrhage
where outcome was incorrectly 'predicted'
patient no. £ admission cause of death
11 0.61 1st oesophageal perforation
21 0.65 1st myocardial infarct
34 0.71 2nd left ventricular failure
following transection
44 0.84 2nd recurrent bleeding, liver
failure
18 0.86 3rd recurrent bleeding, liver
failure
42 0.95 2nd recurrent bleeding, refused
admission
40 0.98 2nd oesophageal tamponade,
respiratory arrest
p = probability of one year survival (see text for calculation)
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elective and emergency shunt patients included in their
study.
Simert and co-workers (1978) studied patients
undergoing elective portacaval shunts and demonstrated
that certain factors such as bilirubin and ascites were
associated with survival at one month and one year.
Albumin was the only other factor associated with
survival at one year. Their study differed from the
present analysis in,that they excluded patients with
very poor liver function whereas this study includes all
patients admitted on an emergency basis with variceal
haemorrhage; this may explain the difference between an
admission mortality of 10% in their study and 31% in the
present series. This would suggest that the timing of
assessment of liver function with regard to the index
bleed should be taken into account when assessing
survival rates. Indeed, in the present series of
patients it has been shown that 15 of the 58 patients
who survived the first week of admission to hospital
changed their modified Child's grading and in all but
three, there was an improvement in grading. Smith and
Graham (1982) have suggested that such an improvement in
Child's classification is rare and if this system is
used to select patients for shunt surgery, the resultant
delay is more likely to lead to death, rebleeding and a
deterioration in grading. In the present study,
regrading at one week following the index bleed did not
better separate those patients who survived admission
from those who did not. Similarly 'prediction' of
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outcome at one year was not affected by reassessing the
patients modified Child's grade at 7 days.
Several workers have used both Child's
classification (Resnick et al, 1974; Orloff et al, 1980)
or one of its modifications (Pugh et al, 1973; Johnston
et al, 1981; MacDougall et al, 1982; Terblanche et al,
1983) to assess liver function in the management of
variceal haemorrhage. Campbell and colleagues (1973)
modified Child's grading by scoring each of the
individual five parameters of liver function. This
separated high and low risk patients but correctly
identified only 65% and 50% of the long and short term
survivors respectively and the addition of other
preoperative parameters did not improve the predictive
value of the scoring system. Despite the subjectivity
of some of the criteria used by Child, Cello and
colleagues ( 19 81 ) found that outcome was correctly
classified in 70% of patients if only class C was used
to identify high risk. The inclusion of preoperative
haematocrit and serum globulin improved prediction of
early mortality to 88%. However, longterm survival
could not be determined by employing any of these seven
factors, whether used alone or in combination.
In reviewing factors affecting survival following
shunt surgery, Kanel and colleagues (1977) found that
Child's grading of patients was superior to liver
histology and other liver function tests in determining
outcome. The subjectivity of their grading, however, is
highlighted by the observation that grade C patients had
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an extremely poor survival compared to grade B patients
whose longterm survival was, in fact, better than that
of grade A patients. More recently, Grendell and his
colleagues (1983) have suggested that the presence of
panlobular fat on histology of liver biopsy was the best
indicator of one year survival in patients presenting
with acute variceal haemorrhage. Although prothrombin
time, presence of hyaline and haematocrit also predicted
outcome, only the, latter factor improved prediction
beyond the presence of panlobular fat. They concluded
that if a liver biopsy could be obtained, then
histological" features should be used to determine
suitability for shunt surgery. The present study was
not intended as an evaluation of the role of
histological features in predicting outcome and the
presence of a prolongation of prothrombin time may
prevent this investigation from being undertaken.
Assessment of hepatocellular damage may have a role in
prediction given that serum markers of liver cell damage
such as SGOT may be useful in determining outcome.
Orloff and colleagues ( 1 980 ) have previously suggested
that this biochemical marker is useful in this context
and Graham and Smith (1981) have shown that survival at
one year is only 5% for patients with a value greater
than 100 U/l before shunt surgery whereas survival was
36% for patients celow this preoperative level. This
study shows no such association with median values of 34
and 35 U/l (ALT) in those who survived and did not
survive to one year. The present analysis, however,
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does not rule out the possibility that this liver
function test may be important in patients submitted to
shunt surgery.
In the present study, the one year mortality of
65% in patients assigned to a modified Child's grade C
at initial presentation is comparable to that reported
in other series (Table 1.2). However, since this group
of patients comprised 71% of the present patient
population, the classification is not sensitive enough
to define risk for individual patients. On the other
hand, regression analysis allows clearer separation of
high and low risk groups of patients, correctly
predicting outcome in 81% of patients. Of the seven
deaths which were incorrectly 'predicted', two followed
treatment complications and two patients died of
myocardial disease. It is arguable whether the patient
who refused to take medical advice would have survived
had he sought admission to hospital. The remaining two
deaths must be seen as failures of the predictive system
when used in patients managed by a policy employing
injection sclerotherapy as its main therapeutic option.
Although the system can be used as a means of auditing
the present management policy, it remains to be seen
whether it can be applied to groups of patients managed
by other treatments.
There is conflicting evidence as to whether
sclerotherapy improves longterm survival (MacDougall et
al, 1982; Terblanche et al, 1983), although it appears
that the risk of further haemorrhage and its severity
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are reduced by this technique. This seems logical in
that a reduction in the incidence of recurrent variceal
haemorrhage will result in an improvement in mortality
by a decrease in the number of deaths secondary to
haemorrhage and associated liver failure. The study of
Terblanche and colleagues (1983) showed no improvement
in long term survival in the group of patients receiving
elective sclerotherapy compared to the group of patients
receiving sclerotherapy for acute variceal haemorrhage
alone. Although there was a reduction in recurrent
haemorrhage in the treated group, these results suggest
that recurrent haemorrhage can be adequately treated by
acute sclerotherapy and that subsequent deaths result
from progressive deterioration of liver function which
in itself is not affected by sclerotherapy. Of the 23
patients in the present series requiring readmission
with variceal haemorrhage, ten did not survive to one
year but in only four of these patients was death
incorrectly 'predicted' (Table 4.5). These results
would suggest that overall survival would have been
improved had these four patient deaths not been
precipitated by recurrent haemorrhage but long term
survival is more likely to be determined by the
progression of the underlying liver disease and other
factors such as continued alcohol abuse.
Further studies will be required to determine
which therapeutic option minimises the severity and
frequency of such bleeding episodes. It has been
suggested that in all future randomised clinical trials,
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patients should be stratified into good and poor risk
groups by Child's criteria (Graham et al, 1981;
Galambos, 1983). The present analysis suggests that
such scoring systems may not be sufficient to adequately
separate these groups and that such stratification
should be based on the predictive indices identified.
Failure to do so may result in an unfair distribution of
high risk patients between treatment groups. The effect
of a change to a more aggressive management policy such
as with stapled oesophageal transection could be
observed outwith a controlled study by use of the
'predictive' system. An unfavourable effect on survival
would be seen if patients who were previously assigned
to the 'good risk' group did not survive to one year.
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CHAPTER 4_
SECTION 2 - PREDICTION OF ONE YEAR SURVIVAL USING FACTORS
MEASURED ONE MONTH FOLLOWING ACUTE VARICEAL
HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Results
(a) Outcome and modified Child's grading




In previous chapters it
the timing of the assessment of
have an effect in determining wh
outcome following acute variceal
some investigators have sugges
Child's grading of patients is of
(Pugh et al, 1973), it has
chapters that it is of limited va
of short and longterm survi
modified Child's grading of patie
first seven days of admission
acute variceal haemorrhage but this change in grading
does not improved its ability to predict outcome.
In order to further investigate the relationship
between timing of assessment of liver dysfunction and
prediction of outcome, risk factors, recorded one month
following the index variceal bleed, were submitted to
further analysis.
ii. PATIENTS AND METHODS
The patient population studied included 38
patients described in the previous section who survived
to be assessed at one month from their initial admission
with variceal haemorrhage and were entered into an
elective sclerotherapy programe.
For the purposes of the present analysis, a
further 15 patients referred from other hospitals one
month following their index variceal bleed are
has been suggested that
liver dysfunction may
ich factors may predict
haemorrhage. Although
ted that the modified
value in this context
been shown in previous
lue in the prediction
val. Furthermore the
nts changes within the
to hospital following
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included. Of these patients, seven were referred prior
to September 1982 and have not been included in previous
analysis because of the anticipated effect of their late
referral on subsequent survival rate (Graham and Smith,
1981). The remaining eight patients were seen after
September 1982 at which time a study assessing the value
of propranolol in preventing recurrent variceal
haemorrhage had been commenced. These patients did not
satisfy the entry criteria to the study and underwent a
programme of longterm injection sclerotherapy as
outlined in the previous section and in Chapter 2.
There were 35 males and 18 females with a mean age
of 62 (range 17-73 years). The cause of portal
hypertension in these patients was alcohol cirrhosis (34
patients), chronic active hepatitis (4 patients),
cryptogenic cirrhosis (6 patients), primary biliary
cirrhosis (2 patients), portal vein thrombosis (2
patients), idiopathic portal hypertension (2 patients),
post-hepatitic cirrhosis (1 patient), pancreatic
carcinoma (1 patient) and unknown (1 patient).
Sixty-four per cent of patients therefore had alcohol
associated cirrhosis.
Patient assessment was undertaken at the time of
the patient's first elective admission which in all
instances was between 3-5 weeks following their initial
admission to the Royal Infirmary or the referring
hospital with acute variceal haemorrhage. The clinical,
biochemical and haematological indices of liver function
measured were those recorded in Chapter 3 and Section 1
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of Chapter 4. The potential predictive factors were
analysed by Student's t, Mann-Whitney and Chi squared
tests. Stepwise logistic regression analysis was used
to identify those variables which had independent
significance and to minimise the number of admission
factors needed for optimal separation of those patients
who survived and those who did not survive to one year.
iii. RESULTS
(a) Outcome and Modified Child's Grading
Thirty four patients (64%) survived to one year
and during this time 15 of these had further variceal
haemorrhage which required acute sclerotherapy. Of the
19 patients who did not survive to one year, 13 patients
died of liver failure (in six haemorrhage precipitated
admission), one patient died of left ventricular failure
following emergency stapled oesophageal transection, one
patient died with a severe coagulopathy following
haemorrhage from a gastric varix, in one patient
treatment was withdrawn following admission, one patient
died of a cerebrovascular accident and two patients died
from their pancreatic and gastric carcinomas.
Outcome is shown for 53 patients as graded by
Pugh's modification of Child's classification (Table
4.6) (one patient - no serum albumin recorded).
Seventy-two patients were assigned to grades A and B.
Only one-third of the grade C patients survived to one
year. Using grades A and B as good risk and grade C as
bad risk, outcome was correctly predicted in 74% of
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TABLE Modified Child' s classification and one year
survival in 53 patients assessed one month
following admission with acute variceal
haemorrhage
grade n^ dead at 1_ year
A 16 2(13%)
B 21 6 (29%)
C 15 10 (67%)
no grade 1 1
Total 53 19 (36%)
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admissions.
(b) Potential Predictive Factors and One Year Survival
Only three individual risk factors obtained from
the 53 patients demonstrated a significant association
with one year survival (Tables 4.7 and 4.8). Stepwise
logistic regression analysis showed that albumin (ALB),
white cell count (WBC), haemoglobin (Hb.) and age (in
decreasing order of significance) were independent
predictors of one year survival. The derived regression
equation allows estimation of the predicted probability
of survival. The relationship between the probability
of discharge and the four predictors is given by
log (p/1 -p)= -5.2 + 0.11 ALB -0.45WBC -0.45Hb -0.04(age)
where the actual values of all the variables are
entered.
The relationship between individual values of p
and death or survival at one year in these patients is
shown in Figure 4/2 (p not calculated in four patients
with unrecorded values). Decreasing values of p were
associated with increasing risk of death; for example
there were seven deaths in 38 admissions (18% mortality)
when p>0.5 (low risk) and there were nine deaths in 12
admissions (75% mortality) when p<0.5 (high risk). In
five of the seven deaths in the low risk group, death
was due to progressive liver failure. One patient died
in left ventricular failure in the immediate
postoperative period following stapled oesophageal
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TABLE 4_.7_ Categorical variables and one year survival
























TABLE 4.8 Relationship between continuous variables
and one year survival in patients assessed
at one month following acute variceal
haemorrhage
factor alive dead
n value n value
albumin 34 34.9 + 5.5* 18 30.2 + 5.8*
PTR 34 , 1-3 + 0.2* 19 1.4 + 0.2*
protein 33 70.9 + 8.7 18 66.5 + 11.4
age 34 49.2 4- 13.4 19 54 .4 + 12.0
bilirubin 34 27 19,44 19 30 20,69
ALT 34 31 17,54 19 34 19,56
APH 34 326 206,419 19 345 193,848
WBC 34 6.3 + 3.1 17 7.5 ± 3.3
haemoglobin 34 12.2 + 2.4 19 11.9 + 1.8
KCCR 34 1 .3 + 0.2 17 1.3 + 0.2
TR 34 1 .1 + 0.7 17 1 .0 + 0.6
platelets 34 139 107, 18 19 1 14 83,201
urea 34 4.7 3 .2,5. 16 5.1 3.8,7.1
creatinine 34 76 70,85 16 85 73,115
MLD 34 13 2,52 19 9 2,48
MFB 34 3 1,12 19 1 1,9
value = mean +■ SD or median and quartile as appliable
*p<0.05
PTR = prothrombin ratio;
ALT = alanine aminotransferase;
APH = alkaline phosphatase;
WBC = white cell count
KCCR = kaolin cephalin clotting ratio;
TR = thrombin ratio;
MLD = duration of liver disease in months;





+ + a a + + d a
Alive □ ® Bled
• + No bleed
□
D
□ □ a □ □
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FIGURE 4/2 Probability of one year survival (p) for
patients assessed one month following
acute variceal haemorrhage. For calculation
of p values, see explanation in text. An
arbitrary cut-off value of p = 0.5 has
been chosen to define 'high risk' (p<0.5)
and 'low risk' groups (p>0.5).
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transection for recurrent variceal haemorrhage and the
seventh patient died when a positive decision was made
to withdraw treatment. The outcome was correctly
'predicted' in 70% of admissions using this p value of
0.5 as an arbitrary discriminant between 'low' and 'high
risk ' groups.
Figure 4/2 also demonstrates the distribution of
those patients experiencing further variceal haemorrhage
during follow-up. The incidence of rebleeding is
similar in both those patients who survived to one year
(45%) and those patients who did not survive to one year
(50%). Five of the seven patients who died in the 'low
risk' group experienced recurrent variceal haemorrhage
during the period of follow-up.
iv. DISCUSSION
Whereas 71% of patients were assigned to grade C
at the time of acute variceal haemorrhage (section 1),
72% of the group of patients assessed one month after
variceal haemorrhage were assigned to the 'good risk'
grades A and B by the modified Child's classification
(Pugh et al, 1973)- The change in the relative numbers
in these grades must be accounted for by the high
admission mortality of those patients assigned to
modified Child's grade C at the time of their acute
variceal haemorrhage and by an improvement of liver
function in those patients surviving to be readmitted
one month following this index bleed. This selection of
patients has resulted in only 15 patients being assigned
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to a modified grade C and only five (33%) of these
patients survived to one year whereas only eight (21%)
of 37 patients assigned to grades A and B did not
survive this period. Using the five variables of
ascites, encephalopathy, albumin, bilirubin and
prothrombin time, outcome at one year has been correctly
'predicted' in 74% of patient admissions. There has
been, therefore, a considerable improvement in the
ability of the modified Child's classification in
predicting outcome when it is used to assess liver
dysfunction one month following acute variceal
•<
haemorrhage as compared to its usefulness within the
first week of the patient's admission to hospital with
acute variceal haemorrhage.
Univariate analysis has identified only three
factors, namely albumin, prothrombin ratio and the
presence of ascites, which have significant association
with outcome. However, stepwise logistic regression
analysis has shown that albumin, white cell count,
haemoglobin and the patient's age were independent
predictors of one year survival. These results must be
interpreted with some caution given the small numbers of
patients included for analysis. Furthermore, it can be
argued that the addition of 15 patients not previously
included in the analysis of risk factors at the time of
admission, may adversely affect the present results.
Nonetheless, this group of patients have selected
themselves in the same way that the remaining 38
patients have survived to be readmitted one month after
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their index bleed for elective sclerotherapy.
It is of interest to note that serum albumin has
emerged as a predictor of one year survival. Previous
analysis has shown that this variable, when recorded
immediately at the time of the patient's initial
admission with variceal haemorrhage, is of no value in
determining outcome. Its inclusion in both Child's
original and Pugh's modified classifications is
supported by the present analysis only when liver
dysfunction is assessed well after the index variceal
haemorrhage. Surprisingly, Malt and Malt (1979) noted
that the first recorded serum albumin measured after
admission for shunt surgery was the strongest predictor
of longterm survival and later measurements were of
limited value. In their group of elective patients, it
was postulated that the infusions of albumin and blood
products might effect subsequent serum albumin levels.
It is possible that albumin is of no prognostic value at
the time of acute variceal haemorrhage because serum
albumin levels will fall when blood loss is replaced
with crystalloid infusions in some patients and will
rise in those patients who receive infusions of albumin
and fresh frozen plasma. Its emergence as a predictor
of outcome when the patient has recovered from his or
her index variceal bleed, suggests that it may be a
useful indicator of liver dysfunction and longterm
survival. Although univariate analysis demonstrates an
association between outcome and two other factors used
in the modified Child's classification, multivariate
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analysis has shown that both ascites and prothrombin
ratio are of limited value in determining outcome when
they are recorded one month following the variceal
bleed.
No previous study has attempted to define the
importance of timing of liver dysfunction with regard to
outcome. Christensen and colleagues (1984) have looked
at the prognostic value of the Child's criteria in
medically treated cirrhosis in patients who had not
previously experienced variceal haemorrhage. Their study
demonstrated a decreased survival rate with increasing
degree of abnormality of serum albumin, ascites,
bilirubin and nutritional status. Survival was not
significantly influenced by neurological status.
However, in a further study of 488 placebo or
prednisone-treated cirrhotic patients (Schlichting et
al, 1983), only ascites of the 12 potential prognostic
variables was of value in determining survival. In
analysing the results of these studies, one difficulty
which is not shared by the present series is the problem
of deciding a starting point when assessment can be made
during the disease process. Analysis of the present
data has looked at survival with an index variceal bleed
representing the starting point. This represents only
one manifestation of portal hypertension and
investigators looking at survival in cirrhosis have
merely used referral to hospital as the starting point
of these patients liver disease. In the present study,
duration of antecedent liver disease has not been shown
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to be associated with outcome following acute variceal
haemorrhage although paradoxically the median value is
greater for those patients who survive to one year.
The ability of the present prognostic index to
discriminate between 'high' and 'low' risk groups of
patients has been reduced due to the small number of
patients studied and it has accordingly included a
number of apparently unrelated variables. It is
difficult to account for the potential prognostic value
of the white cell count which was lower in those
patients who survived to one year. It may be that the
development of hypersplenism in these patients results
in a reduction in portal venous pressure and that an
elevated white cell count in those alcohol cirrhotic
patients who die might indicate continued alcohol
abuse. The similar values for haemoglobin in both those
patients who survived and those who died does little to
explain its emergence as a potential prognostic factor
but the fact that the age of patients who survive is
less than those who died is readily understandable. The
loss of ascites as a determinant of survival may be
accounted by the smaller number of patients with
detectable ascites or by the fact that many patients
will have been on diuretic therapy. Hypoalbuminaemia
may be a more sensitive indicator of fluid retention in
these patients. Only four of the 53 patients had
clinical evidence of encephalopathy and all but one of
these patients did not survive to one year. The
clinical assessment of encephalopathy may not be
- 137 -
sensitive enough to identify patients with severely
compromised liver function and the use of more objective
tests such as electroencephalography and trail testing
(Zeegen et al, 1970) may be of value in this context.
Using the four variables identified by regression
analysis, the prognostic index has correctly 'predicted'
outcome in 70% of patients. It has not been possible to
prospectively assess this prognostic index against a
second independent series of patients, but since the
index will be most accurate in 'predicting' outcome in
the group of patients from whom the data is derived, it
seems likely that its prognostic value will be
diminished in such a prospective series of patients.
Using five variables, the modified Child's
classification has correctly 'predicted' outcome in 74%
of patient admissions. This figure is similar to that
found by Cello and his colleagues (1981) who claimed
that the original Child's classification was the most
important factor in determining early mortality
following elective portacaval shunt. In their series,
outcome was correctly predicted in 77% of their patient
admissions and it is of interest to note that the
percentage of patients assigned to grade C in their
study (34%) is identical to that of the patients in the
present series (33%). By adopting a scoring system of
the five individual factors described by Child, Campbell
and colleagues (1973) were able to predict admission
mortality in 62% of their total patient population. The
results of these studies assessing survival following
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portacaval shunting imply patient selection on the part
of these investigators but confirm that a classification
such as that described by Child may be the most
effective method of assessing risk when liver function
has improved following admission with acute variceal
haemorrhage.
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CHAPTER 5_ APPLICATION OF A PROGNOSTIC INDEX IN A
TRIAL ASSESSING THE ROLE OF PROPRANOLOL
IN THE PREVENTION OF RECURRENT VARICEAL
HAEMORRHAGE
i. Introduction
ii. Patients and methods
iii. Results
(a) propranolol study (1) Glasgow Royal Infirmary
(2) Western Infirmary
(3) All patients
(b) prognostic index and admission survival
(c) use of prognostic index in withdrawing
treatment
(d) prognostic index and management audit
(e) entry into propranolol study based on
prognostic index
(f) effect on one year survival by change in






In Chapter 3, a prognostic index was described
which appeared to offer an accurate means of identifying
a 'high risk' group of patients who were unlikely to
survive admission to hospital when presenting with acute
variceal haemorrhage. This index, based on admission
prothrombin ratio, serum creatinine and encephalopathy,
was validated in a small prospective series of patients
treated by an identical management policy. It was
suggested that it could be used to identify those
patients whose prospect of surviving was so poor that
they should be denied active treatment and could provide
a useful means of auditing management policy of acute
variceal haemorrhage. In Chapter 4, a prognostic index
for one year survival was outlined and this incorporated
the same indices of liver function as predicted
admission mortality. By using the one year prognostic
index it appeared that most deaths occurring within one
year of presentation were due to the progression of the
liver disease when sclerotherapy was used to prevent
recurrent variceal haemorrhage. It was suggested that
the prognostic index might be used as a means of
selection for entry to clinical trials.
Since September 1982 a study has been undertaken
between the University Department of Surgery, Glasgow
Royal Infirmary and the Gastroenterology Unit, Western
Infirmary, Glasgow to determine the role of propranolol
in the prevention of recurrent variceal haemorrhage. It
has been suggested by Lebrec and colleagues (1980) that
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beta blocker therapy and propranolol in particular may
reduce the risk of gastrointestinal bleeding in patients
with portal hypertension by a reduction in portal venous
pressure. These same investigators (Lebrec and
colleagues, 1981) showed a significant reduction in the
incidence of rebleeding but a similar controlled study
has been unable to confirm this observation (Burroughs
et al, 1983) .
The preliminary results of this ongoing study will
be presented but the aim of the present analysis is
1. to examine whether the admission prognostic
indices for all patients and alcohol cirrhotic patients
can still be used to identify 'high risk' and 'low risk'
patients presenting with acute variceal haemorrhage from
September 1982 to Glasgow Royal Infirmary.
2. to determine whether assessment using the
admission prognostic index identifies patients who
should be denied active treatment when admitted to
Glasgow Royal Infirmary.
3. to determine whether assessment of the
probability of discharge or death following admission
allows continuing audit of the managment policy for
acute variceal haemorrhage in patients presenting to
Glasgow Royal Infirmary.
4. to establish whether the use of the admission
prognostic index could have improved patient selection
for the propranolol study by excluding those patients
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unlikely to survive admission to hospital.
5. to examine the effect of a change in
management policy on longterm survival by using the one
year prognostic index.
6. to determine whether the one year prognostic
index is applicable to the group of patients managed in
the Western Infirmary and whether differences in
survival rates are related to the type of patient or
differences in management policy.
ii. PATIENTS AND METHODS
Data were collected prospectively on 60 new
patients presenting on 85 occasions to the Glasgow Royal
Infirmary from September 1982 to March 1985 when a study
assessing the efficacy of propranolol in the longterm
management of variceal haemorrhage was being
undertaken. All patients have been followed up for one
year to March 1986. During this same period, seven
patients who had been previously admitted with variceal
haemorrhage before September 1982 presented with further
variceal haemorrhage on ten occasions giving a total of
67 patients presenting on 95 occasions to the Glasgow
Royal Infirmary. The admission data of 30 patients who
presented to the Gastroenterology Unit, Western
Infirmary during the same period were reviewed.
Patients admitted to Glasgow Royal and Western
Infirmaries with endoscopically proven haemorrhage from
oesophageal varices were treated initially by balloon
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tamponade followed by injection sclerotherapy. In the
Royal Infirmary the injections were carried out using
the rigid Negus oesophagoscope under general anaesthesia
as previously described but at the Western Infirmary a
fibreoptic endoscope and Williams tube were used under
diazepam sedation. Standard measures were used to
resuscitate patients and correct coagulation defects and
liver failure as previously described in Chapter 2.
Patients under 80 years of age with portal hypertension
secondary to cirrhosis and with endoscopically proven
recent haemorrhage from oesophageal varices were
considered for inclusion into a study to determine the
effect of propranolol on longterm survival and risk of
bleeding. Patients were excluded if there was evidence
on history or examination of overt ischaemic heart
disease, valvular heart disease, hypertension,
congestive cardiac failure, peripheral vascular disease,
cerebrovascular disease, severe chronic obstructive
airways disease, or chronic renal failure. Patients who
had previously undergone surgical treatment of
oesophageal varices or portal hypertension or who had
severe encephalopathy (grade 3 or 4) or hepatorenal
syndrome (serum creatinine >400 ;jmol/l) at the point of
randomisation were not considered. The trial was double
blind, placebo controlled, between patient and
randomised with the aim of entering a maximum of 100
patients followed for a two year period.
Within 72 hours following arrest of haemorrhage by
tamponade and injection sclerotherapy, patients were
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randomly allocated to receive Inderal LA (160 mg once
daily) or matching placebo (1 capsule/day). Informed
consent was obtained from all patients. Drug therapy
was delayed until the patient was haernodynamically
stable and able to understand the aims of the study.
Patients were followed in out-patient clinics with
appointments at 1, 2, 4, 8, 12, 18 and 24 months and
were questioned and examined for a history of
gastrointestinal bleeding, compliance, evidence of
hepatic encephalopathy, resting pulse rate, blood
pressure and ascites. Blood was taken for routine
haematology and biochemistry. Patients were instructed
to report to hospital immediately if haemorrhage
occurred. In this event, endoscopy was carried out to
determine the source of bleeding. If severe haemorrhage
was shown to be variceal in origin or if there was no
other obvious non-variceal bleeding source, then the
patient was recorded as a treatment failure and treated
by balloon tamponade (if necessary) and further
injection sclerotherapy. Severe haemorrhage was defined
by one or more of the following criteria
1. fatal haemorrhage
2. shock (pulse greater than 100/minute; systolic
BP <100 mmHg)
3. initial or subsequent haemoglobin <10 g/dl or
fall in haemoglobin by more than 3 g/dl within 48 hours
of haemorrhage
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4. blood transfusion required within 48 hours of
haemorrhage to maintain the circulation
5. active variceal bleeding at endoscopy
Results are expressed as means and standard
deviations where appropriate and statistical analysis
undertaken by Chi squared and Student's t tests.
Freedom from variceal haemorrhage and survival were
calculated using life table analysis.
The probability of discharge or death and one year
survival were calculated at the time of the initial
admission with variceal haemorrhage for each of the
patients. The equation
log (p/1 -p) = 10.0 -4.3 PTR -0.03 CR -0.85 ENC
was used to predict admission survival and p = 0.66 was
used to separate "high risk' and 'low risk' groups. The
equation
log (p/1 -p) = 11.7 -5.7 PTR -0.02 CR
was used to predict admission survival in the subgroup
of alcohol cirrhotic patients using p = 0.4 as the
cut-off value between 'high risk' and 'low risk'
groups. The equation
log (p/1 -p) = 7.8 -0.76 ENC - 2.7 PTR -0.05 CR
was used to predict one year survival in all patients





(_1_) Glasgow Royal InfIrmary
Sixty-seven patients presented on 95 occasions to
Glasgow Royal Infirmary between September 1982 and March
1985. The mean age of patients was 52 years (range
30-82). There were 44 male and 23 female patients. The
underlying cause of portal hypertension is shown in
Table 5.1. Four patients died because of continuing
blood loss; two patients with severe coagulation defects
continued to bleed despite oesophageal tamponade; two
patients with a history of continuing alcohol abuse and
recurrent variceal haemorrhage were not treated beyond
tamponade. Control of haemorrhage was therefore
achieved on 96% of admissions.
Table 5.2 shows the admission mortality for each
of the modified Child's classification grades. The
overall admission mortality was 21%.
All 67 patients admitted with variceal
haemorrhage, were considered for entry to the longterm
study assessing the efficacy of propranolol in
preventing recurrent variceal haemorrhage. Twenty-five
patients were not suitable for entry into the study.
Thirteen patients died within a mean of 5 days (range
1-14 days) and were not entered to the study because
they were haemodynamically unstable or were unable to
consent to the study. Six patients, all of whom
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TABLE 5_. ]_ Cause of portal hypertension for 67 Glasgow
Royal Infirmary patients admitted on 95
occasions and 26 Western Infirmary patients
presenting with variceal haemorrhage from





alcohol cirrhosis 51 71 16
chronic active 8 12 1
hepatitis
cryptogenic cirrhosis 4 6 3
primary sclerosing 1 3 0
cholangitis
Wilson's disease 1 1 1
carcinoma of pancreas 1 1 0





Total 67 95 26
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TABLE 5_.2_ Control of haemorrhage and admission
mortality in relation to modified Child's
classification in patients presenting to
Glasgow Royal Infirmary with acute variceal

















37 (100%) 2 (5%)
47 (92%) 18 (35%)
Total 67 95 91 (96%) 20 (21%)
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survived admission to hospital, had specific
contraindications to beta blocker therapy. Four
patients, admitted with variceal haemorrhage, were
receiving beta blocker therapy which had been prescribed
for asymptomatic oesophageal varices. These patients
were successfully discharged from hospital following
sclerotherapy. One patient, in whom bleeding persisted
despite sclerotherapy, proceeded to stapled oesophageal
transection. In one patient portal hypertension had
arisen as a result of metastatic pancreatic carcinoma
and she was therefore not considered for the study. She
was discharged from hospital following sclerotherapy and
died within three months. Forty-two patients were
therefore randomised from the Royal Infirmary to the
study.
(2_) Western Infirmary
During this same period, 26 patients were entered
into the study from the Gastroenterology Unit, Western
Infirmary. No data is available on patients excluded
from the study. The mean age of patients was 56 years
(range 35-75 years). The underlying cause of portal
hypertension is shown in Table 5.1. According to Pugh's
modification of Child's classification, there were seven
grade A, 12 grade B and 7 grade C patients.
(_3) All patients
Details of the 68 patients entered into the study
from both hospitals are given in Table 5.3. Follow-up
was for a minimum of 12 months. Thirty-three patients
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TABLE 5.3^ Details of 68 patients presenting with acute
variceal haemorrhage to Glasgow Royal
Infirmary and Western Infirmary entered into
a study assessing the efficacy of propranolol
in preventing recurrent variceal haemorrhage
propranolol placebo
number 33 35
male/female 21 : 12 20 : 15
mean age (years) 56 52
(range) (30-73) (29-75)
mod. Child's grade 5 13 15 5 18 12
A. B. C.
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were randomised to propranolol and 35 to placebo and the
groups were well matched with respect to sex, age and
modified Child's grading.
Twenty-six of 35 patients in the placebo group
(74%) rebled whereas 18 of 33 patients in the
propranolol group (55%) had further variceal haemorrhage
(Table 5.4). This difference was not significant.
Mortality in both groups was not significantly different
with 11 patients (33%) in the propranolol group and 15
patients (43%) in the placebo group dying before two
year follow-up. Three deaths in the propranolol group
and ten deaths in the placebo group were thought to have
been precipitated by recurrent variceal haemorrhage.
Survival curves for first bleeding episode and for death
have been calculated by life table analysis and are
shown on Figure 5/1 and Figure 5/2 respectively.
(_b) Prognostic index and admission survival
The relationship between individual values of p
for all Glasgow Royal Infirmary patients and death or
discharge is shown in Figure 5/3. There were five
deaths in 74 admissions (7% admission mortality) when p
was greater than 0.66 ('low risk') and there were 15
deaths in 21 admissions (71% mortality) when p was less
than 0.66 ('high risk'). All five deaths in the 'low
risk' group (Table 5.5) appear to be unrelated to the
severity of the liver disease. Outcome was correctly
predicted in 88% of admissions using 0.66 as the cutoff
point between 'high' and 'low risk' groups.
Using the logistic regression equation obtained
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TABLE 5_.4_ Mortality and incidence of rebleeding for













































FIGURE 5/1 Duration of survival (life table analysis)
of patients entered into study assessing
the role of propranolol in the longterm
management of variceal haemorrhage.
The number of patients alive at the
beginning of each six month period is


























FIGURE 5/2 Risk of rebleeding (life table analysis)
of patients entered into study assessing
the role of propranolol in the longterm
management of variceal haemorrhage.
The number of patients free of variceal
bleeding is shown for the beginning of
each six month period for both placebo
and propranolol (prop.) groups.
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TABLE 5_.5_ ' Low risk ' patients admitted between September
1982 and March 1985 with acute variceal
haemorrhage and in whom outcome of admission
was incorrectly 'predicted'




























0.85 sudden death, ?MI



















6 th 0.52 treatment withdrawn
4th 0.63 treatment withdrawn
3rd 0.54 treatment withdrawn
3rd 0.64 bronchopneumonia, LF
3rd 0.76 uncontrolled
haemorrhage
1 st 0.58 liver failure
1 st 0.55 MI
1st 0.63 liver failure
1 st 0.81 perforated
oesophagus
1 st 0.82 CVA,
bronchopneumonia
1 st 0.99 Staph, pneumonia, LF
AC = alcohol cirrhosis;
CAH = chronic active hepatitis
MI = myocardial infarct;
CVA = cerebrovascular accident
LF = liver failure
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for alcohol cirrhotic patients, the relationship between
individual values of p and outcome for the Glasgow Royal
Infirmary alcohol cirrhotic patients alone is shown in
Figure 5/4. There were 11 deaths in 63 admissions (17%
admission mortality) when p was greater than 0.4 ('low
risk') and seven deaths in eight admissions (88%
admission mortality) when p was less than 0.4 ('high
risk'). The 11 deaths in the 'low risk' group are
listed in Table 5.5. Outcome was correctly predicted in
83% of admissions.
(c) Use of prognostic index in withdrawing treatment
Of the 15 Glasgow Royal Infirmary patients whose
probability of discharge was less than 0.4, only one
patient survived (Figure 5/3). This patient was known
to have a past history of chronic renal failure and on
admission had a serum creatinine of 450 pimol/1. He was
still alive 12 months after his initial admission to
hospital, there having been an increase in his
creatinine to 500 pmol/1. All 14 remaining patients
died primarily because of progressive severe liver
failure.
There were only seven patients amongst the
subgroup of alcohol cirrhotic patients whose probability
of discharge was less than 0.4 and only one of these
patients (p value 0.27) survived (Figure 5/4). This was
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FIGURE 5/3 Prediction of outcome (p) following admission
for acute variceal haemorrhage in 67 patients
presenting to Glasgow Royal Infirmary on 95
occasions with acute variceal haemorrhage
between September 1982 and March 1985. For
calculation of p, see text. An arbitrary
cut-off value of 0.66 separates 'high risk'
















FIGURE 5/4 Prediction of outcome (p) following admission
for alcohol cirrhotic patients presenting to
Glasgow Royal Infirmary between September
1982 and March 1985- For calculation of p,
see text. An arbitrary cut-off value of
0.4 separates 'high risk' (p<0.4) and
'low risk' (p>0.4) groups.
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(d) Prognostic index and management audit
Table 5.5 lists those 'low risk' patients from
Glasgow Royal Infirmary in whom outcome of admission was
incorrectly 'predicted'. One death (MM) resulted from a
definite complication of therapy and in a further
patient (HS) a severe staphylococcal pneumonia failed to
respond to treatment following tamponade and
sclerotherapy. The remaining three deaths were due to
disease processes apparently unrelated to the underlying
liver disease.
Of the alcohol cirrhotic patients with a p value
greater than 0.4, two patients (CO, WM) who died of
progressive liver failure must be regarded as failures
of the predictive system. Two further patients (DJ, HS)
died with progressive liver failure but this was
associated with severe chest infections which did not
respond to treatment. The patient who died as a result
of an oesophageal perforation was amongst the group of
alcohol cirrhotic patients who should have survived, and
in a further patient (JJ) surgery for a bleeding gastric
varix was delayed when it was not recognised that
tamponade had failed to control haemorrhage. This
patient subsequently died of a severe coagulopathy
following emergency laparotomy for ligation of the
bleeding gastric varix.
(e_) Entry into propranolol study based on prognostic
index
During the study period, 25 of 67 patients
admitted to Glasgow Royal Infirmary were not suitable
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TABLE 5.6 'Low risk ' patients entered into the
propranolol study and in whom one year













































for entry into the study. The reasons for exclusion
have previously been outlined. The prognostic index
correctly 'predicted' outcome in ten of the 13 patients
who did not survive their initial admission to hospital;
the remaining three patients died from a myocardial
infarct, staphylococcal pneumonia and a cerebrovascular
accident. All six patients not entered on medical
grounds survived admission but two of these patients had
a probability of discharge less than 0.66; one patient
had an admission serum creatinine of 450 pmol/1 and the
second patient whose probability of discharge was 0.62
survived. All four patients receiving prophylactic
administration of propranolol at the time of admission
with variceal haemorrhage were correctly 'predicted' to
survive admission. In both the patient with pancreatic
carcinoma and the patient requiring stapled oesophageal
transection, discharge from hospital was correctly
'predicted ' .
The forty-two patients from Glasgow Royal
Infirmary were equally randomised to receive propranolol
or placebo. The admission prognostic .index correctly
predicted that one patient in each group would not
survive admission to hospital. In three.patients in the
'high risk' group (2 placebo, 1 propranolol), the index
was incorrect in 'predicting' that the patients would
not survive admission but the patient randomised to
receive propranolol died at home four weeks later with
massive haemorrhage. In one patient who did not survive
admission, outcome was incorrectly 'predicted'. This
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was the patient referred to in Table 5.5 who died
result of an oesophageal perforation (MM).
All patients in the Western Infirmary
survived admission to hospital, although two
assigned to the 'high risk' group.
(£) Effect on one year survival by a change in
management policy
(J_) Glasgow Royal Infirmary
Of the 25 patients excluded from the propranolol
study, 16 patients did not survive to one year and in
two patients outcome was incorrectly 'predicted' (Figure
5/5) when using the one year prognostic index. Patient
MP (Table 5.6) was thought to have died with a
myocardial infarct within 48 hours of admission to
hospital. Patient JM died of her metastastic pancreatic
carcinoma within 3 months of presentation. Nine
patients survived to one year and in four of these,
outcome was incorrectly 'predicted'.
There were 11 'high risk' and ten 'low risk'
patients allocated to the placebo group (Figure 5/5).
ts, two occurred










Of the seven deaths in these 21 patien
in the 'low risk' group (Table 5.6).
patients (HT) has previously been dis
of a myocardial infarct on her th
hospital with recurrent variceal
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FIGURE 5/5 Prediction of one year survival in patients
considered for entry to propranolol study.
Values of p (prediction of one year survival)
are given for patients excluded and those
entered into the study from Glasgow Royal
Infirmary (GRI) and Western Infirmary (WIG).
For calculation of p, see text. An arbitrary
cut-off value of 0.5 separates 'high risk'
(p<0.5) and 'low risk' (p>0.5) groups.
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to one year.
Of the 21 patients randomly allocated to the
propranolol group, ten were from the 'high risk' and 11
from the 'low risk' groups (Figure 5/5). All eight
deaths in these 21 patients occurred in the 'high risk'
group. Two of the 'high risk' patients in the
propranolol group survived to one year.
(2_) Western Infirmary
Ten of the 26 patients entered from the Western
Infirmary died within one year. Seven of these deaths
were in the 'high risk' group but three patients (WB,
NG, MM - Table 5.6) were expected to survive. One
patient with good liver function died because of failure
to control variceal haemorrhage by tamponade and
sclerotherapy, a further patient continued to bleed from
varices despite repeated attempts at sclerotherapy and
before emergency transection could be undertaken, and a
third patient, who sustained a perforation of his
oesophagus at attempted sclerotherapy, died with
septicaemia following stapled oesophageal transection.
Twelve of the 26 patients were randomised to the
propranolol group and 14 to the placebo group (Figure
5/5). There was a similar distribution of relative risk
patients between the two groups, there being five 'high
risk' patients in the placebo and four 'high risk'
patients in the propranolol group.
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(_3) All patients
Of the 68 patients entered into the study, 30 were
assigned to the 'high risk' group according to the
prognostic index but these patients were relatively well
distributed between the treatment groups (14
propranolol, 16 placebo). The number of 'high risk'
patients who died was nine (56%) in the placebo and 11
(79%) in the propranolol group. The predictive system
identified the five placebo patients who were assigned
to the 'low risk' group and were expected to survive to
one year (Table 5.6). The reasons for their deaths have
been discussed above.
iv. DISCUSSION
The preliminary results of this ongoing study of
the effect of propranolol on the prevention of recurrent
variceal haemorrhage are inconclusive due to the small
numbers included in the study, although there does
appear to be a beneficial effect with propranolol. The
rebleeding rate was 55% for patients who received this
drug compared to 74% in those patients who did not.
Lebrec and his colleagues (1981) showed a significant
reduction in the risk of recurrent gastrointestinal
bleeding one year after inclusion into the study from
50% in the placebo group to 4% in the propranolol
group. Only two of the 38 (5%) propranolol and four of
the 36 (11%) placebo patients died within one year in
their study compared to a mortality rate in the present
study of 33% and 43% for the propranolol and placebo
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groups. Burroughs and colleagues (1983) failed to show
any reduction in rebleeding rates in an unselected group
of portal hypertensive patients with varying causes of
cirrhosis and differing severities of liver disease.
During the follow-up period of up to 21 months, 12 of 26
patients in the propranolol group and 11 of 22 in the
control group experienced rebleeding from oesophageal
varices. The 74% rebleeding rate in the placebo group
in the present study is considerably greater than the
50% rate seen in both the study of Lebrec and colleagues
(1981) and Burroughs and colleagues (1983) - This may be
due to a longer period of follow-up of patients with
more severe liver dysfunction. Although Burroughs and
colleagues (1983) conclude that their study is of an
unselected group of patients, only five of 48 (14%)
patients were assigned to modified Child's grade C
compared to the 40% in the present study. Furthermore
there have been a large number of exclusions in this
study which suggest that even if propranolol is
effective in reducing the risk of further variceal
haemorrhage, its use may be limited to a small number of
patients.
During the 30 month period of patient recruitment
for this prospective study assessing the role of
propranolol in the prevention of recurrent variceal
haemorrhage, 26 patients were admitted to the Western
Infirmary and 67 patients presented on 95 occasions to
the Glasgow Royal Infirmary. All patients admitted to
the Western Infirmary survived admission but data is not
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available for those patients who were excluded from
entry to the propranolol study. The 21% admission
mortality for the Royal Infirmary patients represents a
slight improvement in the 28% rate seen over the
preceding 36 month period (Table 2.2). Although this
fall in mortality can be accounted for by the reduction
in the number of grade C patients from 71% to 51%, the
fall in admission mortality is more closely matched by
the decrease in the number of 'high risk' patients as
assessed by the admission prognostic index from 26% to
22%.
Although the cost of treating variceal haemorrhage
by sclerotherapy is considerably less than for surgical
management (Chung et al, 1983), clinicians remain
concerned about the considerable strain imposed upon
hospital resources by the management of acute variceal
haemorrhage in patients whose longterm survival is
limited (Leader, British Medical Journal, 1981). It has
previously been suggested that the admission prognostic
index could conceivably be used as a means of
identifying patients whose prospects of surviving
admission are so low that they should be denied active
treatment. In Chapter 3, it was seen that none of the
13 patients with a prognostic index less than 0.2
survived admission to hospital and in the present review
of 95 Royal Infirmary admissions, only one of the 15
patients with a p value less than 0.4 was still alive 12
months following admission with variceal haemorrhage.
This patient, however, was known to have a degree of
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chronic renal failure and his elevated admission
creatinine was responsible for assigning him to an
adverse risk group despite normal coagulation and the
absence of encephalopathy. Although the index has not
as yet been employed to determine whether therapy should
be continued, it would appear that it would be useful in
this context in guiding the clinician on an early
decision regarding withdrawal of treatment. It is of
interest to note that in the case of three alcohol
cirrhotic patients (Table 5.5), the clinical decision to
withdraw treatment was not supported by the prognostic
index for alcohol cirrhotic patients. However, in these
patients, the decision to withdraw treatment was not
based on the clinical severity of liver disease but on
their repeated admissions due to continued alcohol
abuse.
The prognostic index has again proved useful in
auditing management policy for acute variceal
haemorrhage. Whereas admission mortality in the 'high
risk' group was 84% before September 1982, the mortality
has fallen to 71% since that time. All five deaths in
the 'low risk' group appeared unrelated to the severity
of the underlying liver disease. A similar audit of
management policy employing the prognostic index derived
for alcohol cirrhotic patients has shown that all but
two of the 11 ('low risk') patient deaths in this group
were again unrelated to progression of liver failure.
The emergence of respiratory complications as a common
cause of mortality in these patients gives cause for
- 169 -
concern given that both tamponade and sclerotherapy may
compromise respiratory function during attempts to
control haemorrhage. Oesophageal tamponade has been
implicated in the past as a source of respiratory
complications (Reid et al, I960; Conn et al, 1967) and
it has been suggested by others that medical means of
controlling haemorrhage will not predispose to this
complication (Kravetz et al, 1984; Jenkins et al,
1985). Further studies are required to determine
whether agents such as somatostatin are more effective
in the short term control of variceal haemorrhage.
When undertaking a study to assess the effect of a
particular treatment option such as propranolol on
longterm survival and risk of recurrent variceal
haemorrhage, it would be useful to exclude patients
whose prospect of survival in the short term is poor and
is unlikely to be affected by that particular treatment
option. The criteria drawn up to exclude patients from
entry into the present study of propranolol and
recurrent variceal haemorrhage did not include the use
of a prognostic index. Nonetheless, ten of 13 patients
not entered into the study, whose mean duration of
survival was 5 days, could have been excluded from
consideration for the study at the time of their
admission to hospital by using the admission prognostic
index. Similarly, two patients who were entered into
the study but did not survive admission could have been
identified by such an index and could have been excluded
from the study since short term survival was unlikely to
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have been affected by propranolol. Only two of the
other 12 excluded patients had a prognostic index that
assigned them to a 'high risk' group, although both
survived admission to hospital. All the patients
admitted to the study from the Western Infirmary were in
the 'good risk' group and all survived admission to
hospital. It has previously been suggested that all
randomised clinical trials on variceal haemorrhage
should use Child's criteria to stratify 'good' and 'poor
risk' groups (Graham et al, 1981 ; Galambos 1983 ) but it
has been shown in the previous chapter that these
scoring systems may not be accurate enough to allow such
stratification. This should be based on the prognostic
factors, prothrombin ratio, encephalopathy and
creatinine since the prognostic index has been shown to
'predict' outcome in 81% of admissions.
The 45% one year survival for all patients
admitted from September 1982 was slightly less than the
47% survival when patients were managed by a policy
employing injection sclerotherapy for the longterm
prevention of recurrent variceal haemorrhage. This may
reflect an improvement in longterm management of these
patients, although these figures must be interpreted
with caution given that several variables are involved;
namely the presence of placebo and treatment groups and
the inclusion of patients from a different hospital.
Seventy-nine percent of 'high risk' patients in the
propranolol group died whereas only 58% of 'high risk'
patients died in the placebo group. These results
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suggest that propranolol may have an adverse effect on
liver function and hence survival. This observation is
difficult to interpret but it is well established that
surgical decompression of the portal venous system will
have an adverse effect on longterm survival even in
patients who have never bled from oesophageal varices
(Jackson et al, 1968; Conn et al, 1972). The overall
improvement in survival in the placebo group, however,
suggests a beneficial effect with this drug which is
presumably secondary to the reduction in the rate of
recurrent variceal haemorrhage and this is supported by
the fact that in the placebo group, all five 'low risk'
deaths were associated with recurrent haemorrhage. The
modified Child's grading suggests that there is a slight
preponderance of 'good risk' patients (combined grade A
and B) randomised to the propranolol limb of the study
(55%), although the prognostic index indicates that
there was a greater number of 'high risk' patients in
the placebo group. This latter trend is more in keeping
with the high overall mortality in the placebo group.
Although there is no significant difference between the
two groups in terms of overall mortality, the prognostic
index has clearly shown that five deaths in the placebo
group occurred in 'low risk' patients who would have
been expected to survive. It is difficult to be certain
whether measurement of the prognostic index would have
been more accurate if it had been recorded at a time
when patients had recovered from the insult of their
initial variceal haemorrhage. A delay in randomisation
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would have resulted in probable exclusion of two
patients who did not survive admission to hospital.
The present study suggests that propranolol may
have a role in the management of variceal haemorrhage
but further patients will have to be accrued before this
study identifies those patients likely to benefit from
such therapy. The admission prognostic index has been
shown to be of value in identifying patients who are
suitable for entry into the study and the prognostic
index for one year survival has been used to compare the
patients assigned to the treatment groups. It has shown
that all deaths in 'low risk' patients have occurred in
the placebo group, a trend which is hidden by the
overall results. Furthermore, the value of prognostic
indices has been validated in patients managed by a
similar policy in another hospital. The continued use
of such prognostic indices for monitoring patient
management and selection for entry into clinical studies
seems justified. The admission prognostic index may be
useful in helping the clinician to make an early
decision regarding withdrawal of active support to
patients with severe liver dysfunction.
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CHAPTER 6 SUMMARY AND DISCUSSION
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Although the management of patients presenting
with acute variceal haemorrhage is both time-consuming
and expensive (Chung et al, 1983), few would subscribe
to the view that these patients should be treated to
limited transfusion and sedation (Leading Article,
1981). Although the one year survival for all patients
presenting with variceal haemorrhage to the University
Department of Surgery, Glasgow Royal Infirmary is 48%,
the longterm outlook for these patients may be better
than for many patients undergoing apparent curative
surgery for neoplasia. The large number of alcohol
cirrhotic patients in the present series accounts for
the excess of modified Child's grade C patients whose
one year survival is only 35%. Foster and colleagues
(1970) have shown a two year survival of 85% for alcohol
cirrhotic patients who underwent shunt surgery and
abstained from alcohol compared to a two year survival
of 61% for patients similarly treated but who continued
to abuse alcohol. It could be argued that the clinician
will gain valuable experience from the management of the
alcohol cirrhotic patient and will therefore be better
equipped to deal with other patients presenting with
variceal haemorrhage through no fault of their own but
hospital resources could be better directed if poor risk
patients could be identified at an early stage in
management.
Survival following variceal haemorrhage will be
dependent on the severity of the underlying liver
disease. However, given that variceal haemorrhage
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carries an unfavourable outlook and is one of the more
common modes of death in cirrhotic patients, control of
haemorrhage must be achieved without compromising liver
function. The early prophylactic trials of portacaval
shunting for patients with portal hypertension clearly
showed that this therapeutic option may reduce longterm
survival through an adverse effect on liver function
(Jackson et al, 1968; Resnick et al, 1968; Conn et al,
1972). Conversely, in a study of prophylactic
endoscopic sclerotherapy, Witzel and his colleagues
(1985) have shown a reduction in overall mortality which
was achieved by minimising the frequency of episodes of
variceal haemorrhage.
The policy employed in Glasgow Royal Infirmary has
been successful in gaining immediate control of variceal
haemorrhage. Oesophageal tamponade has arrested
haemorrhage in 90% of patients who continue to bleed on
admission and the associated low morbidity and mortality
in the present series is a reflection of the care that
is taken in managing these patients. Conn and Simpson
(1967) have shown its limitations when used by
non-experienced personnel but their continued criticisms
of its use in their hands seems unjustified due to their
failure to correct deficiencies in their management
policy (Chojkier and Conn, 19 80). Hunt and colleagues
(1982) have more recently shown that it can be used
successfully to arrest variceal haemorrhage. Its
potential for causing respiratory complications has been
recognised in the present series but the evidence
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supporting alternative means of controlling haemorrhage
is conflicting. Vasopressin has not been used in the
Royal Infirmary because of its variable results and
potential hazards. The emergence of somatostatin has
aroused great interest since early controlled studies
show it to be as (Kravetz et al, 1985) or more effective
(Jenkins et al, 1985) than vasopressin and without its
potential hazardous cardiac complications. Furthermore,
recent animal studies, which have suggested that it may
stimulate the reticulo-endothelial system (Baxter et al,
1985) and so provide the prospect of potential
additional benefit in the patient with liver failure.
Macbeth (1955) introduced the technique of
injection sclerotherapy to the United Kingdom and
described its use in 30 patients but emphasised the
importance of chronic injections to try and prevent
recurrent bleeding. In September 1979, when the present
review commenced, injection sclerotherapy had been shown
to be an effective means of controlling haemorrhage
during admission with acute variceal haemorrhage
(Johnston et al, 1973; Terblanche et al, 1979). The 90%
control of haemorrhage is similar to that reported by
these investigators, although the hospital mortality of
28% is slightly higher. This mortality cannot be
accounted by complications of sclerotherapy but by the
severity of the underlying liver disease. It now seems
likely that injection sclerotherapy not only reduces the
number of episodes of variceal haemorrhage (MacDougall
et al, 1982; Terblanche et al, 1983) but also increases
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survival duration (MacDougall et al, 1982). The 48%
incidence of recurrent haemorrhage in the present series
of patients undergoing elective sclerotherapy is similar
to that reported in other centres (MacDougall et al,
1982; Sinnett et al, 1982). Although more frequent
injection of varices in the initial management of
patients results in more rapid obliteration of varices,
it does not appear to significantly reduce the risk of
further variceal haemorrhage (Westaby et al, 1984).
Stapled oesophageal transection has been advocated as a
means of achieving early variceal obliteration
(Johnston, 1982) but as an emergency procedure this
technique carries a high mortality. Longterm
sclerotherapy has yet to be adequately tested against
more aggressive treatment options, although increasing
rebleeding rates are envisaged with longer follow-up of
stapled oesophageal transection (Spence and Johnston,
1985).
Despite this shift from shunt surgery by
clinicians in Europe and the United Kingdom in
particular, portacaval decompression is still commonly
used in the management of the portal hypertensive
patient in the United States of America. Few American
surgeons would favour the approach of Orloff and
colleagues (1980) with regard to emergency portacaval
shunting but the results of Warren and co-workers (1967)
have encouraged many surgeons to pursue a policy of
selective shunting. Although encephalopathy appears
less commonly than with a non-selective shunt (Millikan
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et al, 1985), the latter type of surgical procedure has
yet to be fully evaluated against medical treatment
alone or sclerotherapy. Recent reports regarding
longterm results in the alcohol cirrhotic patient and
subsequent modifications to the operative procedure
suggest that selective shunting may not stand the test
of time (Henderson et al, 1984).
In planning the longterm management of portal
hypertension, the clinician will generally attempt to
select the treatment option for the individual patient.
Conn, on reflecting the poor survival rates following
portasystemic shunting, stated 'that we must learn
either to select better who should be shunted or to
shunt better those we select' (Conn 1974). Although
Child (1964) developed his criteria of liver function to
help in this selection process, their use in the
University Department of Surgery has been limited in the
reviewed patient population, 70% of whom are alcohol
cirrhotic patients. Assessment of potential predictive
factors at the time of admission with acute variceal
haemorrhage has shown that prothrombin time, serum
creatinine and encephalopathy can be used to 'predict'
outcome in up to 92% of patient admissions. The
prognostic index obtained by regression analysis has
been validated in subsequent patient admissions and it
has been shown to be a useful means of auditing the
present management policy for acute variceal haemorrhage
by identifying those patients who died of complications
not related to the severity of the underlying liver
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disease. It has identified patients whose prospect of
survival is so poor that it is debatable whether
resuscitation should have been continued.
Further analysis has shown that caution must be
exercised in translating the value of the prognostic
index to different patient populations. Only
prothrombin time and creatinine were of value in
determining outcome in alcohol cirrhotic patients
presenting with variceal haemorrhage, although it was
gratifying to see that the separation of patients into
'high' and 'low' risk groups by the prognostic index
obtained in these patients was applicable to patients
managed in the Western Infirmary.
Although Graham and colleagues (1981) stated that
Child's criteria do not improve during the course of the
patient's admission to hospital, this study has shown
that patient's grading can improve not just at one month
but within a week following admission with acute
variceal haemorrhage. Reassessment of risk with the
modified Child's classification at one month following
admission with acute variceal haemorrhage improves its
ability to 'predict' longer term survival such that it
is as effective as the prognostic index obtained from
variables recorded at that time. Furthermore the
variables identified by the new prognostic index
differed from those recorded at the time of admission
with acute variceal haemorrhage. Graham and colleagues
(1981) have stressed the importance of timing of entry
into studies and its effect on longterm survival but
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this study has shown that the timing of the assessment
of liver function is equally important in trying to draw
comparisons between different patient populations and
the results of controlled and uncontrolled studies.
The use of a 'predictive' system appears to be
soundly based when applied to . patients managed by
injection sclerotherapy. Using the same 'predictive'
system in the prospective study assessing the value of
propranolol in the prevention of recurrent variceal
haemorrhage, audit did not identify patients whose
survival was adversely affected by administration of
propranolol but it did identify several patients in the
placebo group who died as a result of further variceal
haemorrhage. Although the preliminary results of this
study show no significant beneficial effect with beta
blockade, the 'predictive' system can be used to look
specifically at 'low' risk patients, there being 19
patients in each propranolol and placebo group. There
were no deaths in the propranolol group but five
patients (26%) died in the placebo group.
The 'predictive' system appears to have been of
most value in the prospective study of propranolol in
identifying patients whose longterm survival was
limited. The early demise of these patients during the
study may hide any real effect of propranolol on
longterm survival and exclusion of these patients using
the 'predictive' system would have avoided these
difficulties. Furthermore, by virtue of its clearer
definition of 'high' and 'low' risk groups, it allows
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better comparison of the propranolol and placebo groups
than the modified Child's classification.
In the future it is debatable whether this same
system could be used to identify patients who would
benefit from a more aggressive surgical approach to the
management of variceal haemorrhage. It is probable that
the dividing line between 'high' and 'low' risk groups
with these existing predictive systems would move to
increase the size of the 'high' risk group because of
the greater stress imposed by surgery on the patient's
liver function. Consideration would have to be given to
the timing of the assessment of liver function in
relation to the variceal bleed and operative
intervention. Such assessment of risk and suitability
for surgical intervention might be best undertaken at
the time of variceal haemorrhage when the liver is most
stressed rather than when the patient has recovered.
Future studies in the management of variceal
haemorrhage may require investigation of the
relationship between liver function and portal venous
pressure measurements. The factors determining survival
from the underlying liver disease may differ
considerably from those determining the risk of further
variceal haemorrhage, even although recurrent
haemorrhage appears to be more common in patients with
more severe liver dysfunction. It is conceivable that
patients at risk of recurrent haemorrhage might be
identified more readily by assessment of portal pressure
or variceal size. In the past, portal venous pressure
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measurements have not correlated well with risk of
variceal haemorrhage (Lebrec et al, 1980) but this may
again be accounted for by the timing of the measurement
relative to the variceal bleed. There does, however,
appear to be a relationship between variceal size and
risk of further haemorrhage (Lebrec et al, 1980; Rose et
al, 1983; Witzel et al, 1985) and such subjective
measurements or assessment of intravariceal pressure by
direct (Staritz et al, 1985) or indirect (Gertch et al,
1982) means may be used to identify those patients who
are at risk of early recurrent variceal haemorrhage.
At the present time, prognostic indices provide an
objective means of evaluating patient management and may
allow selection of patients for consideration of other
treatment options. It is conceivable, however, that a
combination of such assessment of liver function and
measurement of variceal pressure will be used in
determining future therapy for variceal haemorrhage.
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3 - 22 pmol/1
3-55 U/l
80 - 280 U/l
2.5 - 8.0 mmol/1
40 - 130 pmol/1
62 - 82 g/1
35 - 55 g/1
male: 13.0 - 18.0 g/dl
female: 11.5 - 16.5 g/dl
4 - 11 x 109/1
150 - 400 x 109/1
patient value (sees)
control value (sees)
control: 12 - 14 seconds
control: 36 - 50 seconds
control: 6 - 9 seconds
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APPENDIX 3.
Summary of methodology used for stepwise logistic
regression analysis.
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Stepwise logistic regression is a method widely
used for the analysis of dichotomous responses when both
continuous and categorical predictor variables are
involved. In the context of the present study, risk of
death following admission with variceal haemorrhage may
be defined as the probability that an individual with
given characteristics will die during that admission.
This probability is the proportion of individuals who
would die within that fixed period, among all those in
the population being sampled who would present with the
given characteristics.
X = (XI, X2 ... Xm) is the set of variables
observed at the time of admission and x = (x1, x2 ...
xm) denotes the particular values observed for each
patient admission. Any presumed relationship between
the probability of death following admission and the
characteristics of the presenting patient may be denoted
by Px = f (0, x). Here Px is the probability in
question (labelled by the independent variable values
x); f is some function; and 0 is a sequence of
population parameters (some numerical quantities which
are assumed to have the same value for all individuals
in the population of interest). By an estimation of the
risk of death (Px) is meant some particular choice of
function (f) and values for its associated parameters
(0). In practice, such estimations are obtained by
assuming a convenient form for f and then estimating 0
for the population of interest from data or a sample of
presenting individuals from that population. The data
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requires the values of the independent variables (X) and
the outcome variable (Y), with Y = 1 if the individual
dies within the defined period (e.g. admission) and Y =
0 if he survives.
The simplest model relating Px to x is the direct
linear one:
m
Px — fx + /Sj x j
where p, B1 ... Bm comprises the population parameters.
This model may be fitted to the data by multiple linear
regression analysis of Y against X. Equation 1 is a
linear regression model for the expected value of Y, as
the expected value of Y (given X = x) is Px. The
validity of equation 1 is questionable because the right
hand side can have values outside the range 0-1 in which
probabilities are defined. A further objection concerns
the distribution of Y (in multiple linear regression, Y
is assumed to be normally distributed with variants
depending upon X; neither condition is satisfied when Y
is dichotomous).
A linear function of the variables such as the
right hand side of equation 1 is relatively easy to
compute and therefore of considerable value when
considering applying estimation scales in practical
settings. In alternative models, Px can be defined by
equating a linear function of the variables with some
transformation of Px which can take on any possible
value. Although several such transformations have
previously been considered, the logistic is the most
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generally acceptable. The logistic transform or logit
of Px is defined by:
a* = i°g [p*/ (1 - p)]
where log denotes the natural logarithm. If Px is the
probability of death, the quantity in brackets is the
odds and therefore the logit can also be called log
odds. The resulting linear logistic model for Px:
\ m _
Ax - /X + J2 Pj xj
i=l
can be fitted to the data by maximum likelihood
estimation. Estimated values of \x can be converted
back to estimated values for Px by use of the
relationship
A
px = 1/(1 + e x)
or the estimated \x can itself be thought of as an
indicator of risk. Maximum likelihood estimation has an
advantage over linear regression analysis in that
minimum assumptions on Y are invoked (the Y variables
are assumed to be independent between subjects and, for
each x, to have a common distribution; no distributional
assumptions on X are made by either method).
Maximum likelihood estimation requires a
repetitious search for the best parameter values and
therefore is far more costly in terms of time than
linear regression analysis, an important consideration
when numbers of variables and many data cases are to be
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studied. This has led to the use of linear discriminant
function discriminating between two populations (in the
present context the subpopulations of those who would
survive or not survive admission) to approximate the
linear logistic function. The linear discriminant
function is also a linear function of the independent
variables, relatively inexpensive to compute and can be
interpreted as a valid estimate of Xx under certain
conditions. The conditions on X are restrictive and are
violated if any of the variables are of the convenient
'yes - no' (dichotomous) type. When these conditions
are not met, the reliability of standard statistical
tests in discriminate analysis is also questionable.
This type of analysis cannot therefore be reliably
performed on the continuous and categorical variables
measured in the present study.
Linear logistic regression employs the general
methodology of maximum likelihood for estimation of the
parameters. An expression can be written for the
probability of the observed Y values occurring, given
the X values and any assumed values for the parameters.
The maximum likelihood estimates for the parameter
values are simply those values which maximise the
probability expression. The 'likelihood' associated
with a given fitted equation is the maximum value.
Larger likelihood values suggest better 'prediction' of
the observed responses by the equation. Means of
assessing the performance of the fitted model is in
terms of the percentage of 'correct classifications' of
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the sample observations. The model yields an estimated
predicted probability (p) of discharge for each patient
and a cut-off point (c) can be chosen so that p < c are
predicted to die (i.e. at 'high risk') and patients with
p > c predicted to be discharged (i.e. at 'low risk').
In this study, the value of c was chosen to provide the
maximum difference in the proportions of patients
classified as high risk between the outcome groups
(patients surviving admission; patients not surviving
admission). This 'percent correct classification', when
derived from the data on which the equation was fitted,
will generally overestimate the performance of the
equation on a fresh sample of data. Hence the need to
verify the predictive system on a second independent
series of patients.
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